curriculum vitae · web viewbot. 55, 730-739. 11. ... tiselius hg, 2001, methods for measuring...

NAME: Saeed R. Khan

ADDRESS: Department of PathologyCollege of Medicine, Box 100275University of FloridaGainesville, Florida 32610

UNIVERSITY EDUCATION:

B.Sc. 1962 Agra University, Agra, India

M.Sc. 1964 Peshawar University, Peshawar, Pakistan

Ph.D. 1973 University of Florida, Gainesville, Florida

CONTINUING EDUCATION:

5. American Urological Association Summer Research Conference, Houston, Texas, August 10-12, 2001

4. Workshop on Molecular Approaches to Kidney and Urologic Problems, Sponsored byNIH/NIDDK, October 19-21, 1990

3. Workshop on Scanning Tunnelling Microscopy, given by Dr. Phillip E. Russell of Materials Science and Engineering Department Center, North Carolina State University,during VIth Annual Meeting of the Florida Society for Electron Microscopy, 1988.

2. Scanning Electron Microscopy and X-ray Microanalysis: Theory and Practice in Biology and Medicine, State University of New York, New Paltz, New York, 1982.

1. Vertebrate Cell and Organ Culture, The W. Alton Jones Cell Science Center, Lake Placid,New York, 1980.

1

PROFESSIONAL EXPERIENCE:

2011 Adjunct Professor, Department of Pathology2012 Finlayson Professor of Urological Research, Department of Urology

1997-2010 ProfessorDepartment of Pathology,

1991 Associate ProfessorDepartment of Pathology

1987 Assistant ProfessorDepartment of Pathology

1985 Associate Research ScientistDepartment of Pathology,

1982 Assistant Research ScientistDepartment of Surgery/Urology,

1979 Assistant in SurgeryDepartment of Surgery/Urology

1978 Postdoctoral FellowDepartment of Pathology

1976 Assistant ProfessorBiology DepartmentKing Abdulaziz UniversityJeddah, Saudi Arabia

1974 University Research FellowPlant Pathology DepartmentUniversity of Adelaide,Adelaide, Australia

1973 Assistant ProfessorInstitute of Biological SciencesIslamabad University, Islamabad, Pakistan

1964 Lecturer in Biology, Directorate of Education, NWFP Region,Peshawar, Pakistan

2

TEACHING EXPERIENCE:

2006-2010 Lecturer, Special Topics in Pathology, Cellular and Molecular Basis of Kidney Diseases

2004, 06 Coordinator, Special Topics in Pathology, Cellular and Molecular Basis of Kidney Diseases

1991-02 Mechanisms of DiseaseCoordinator and Lecturer Graduate Course

1989-95 Systemic Pathology III,(Medical Students)

1989 Special Topics in Pathology,Graduate Course

1989 Workshop on "Biological X-rayMicroanalysis" to Members of FloridaSociety for Electron Microscopy,

1988 Biology and Taxonomy of Ascomycetes& Their Imperfect Stages, and Lichens,Graduate Course

1973,74 Cell BiologyGraduate Course

1973,74 Mycology Graduate Course

1972 Electron Microscopy and Cytochemistry,Teaching Assistant

1964-70 Undergraduate General Biology Undergraduate Botany

GRADUATE COMMITTEE ACTIVITIES

Department of Pathology and Laboratory Medicine

3

Doctoral DissertationChairman

Jayashree A. Gokhale, 1995Joanne Johnson-Tardieu, 1998

MemberLiliana Guedez 1995Ying Yu 1995Christy Myrick 1995Brian E. Szente 1993Michael Ambrose 1993Lucia Fernandes Aleixo 1996

Masters Thesis:Chairman

Suzanne A. Maslamani 1998Julie M. Norton-Fasano 1999Marie E. Buie 2001

MemberMonique Y. Huggins, 1995Xin (Cindy) Zhang, 1995Xianggao Ye, 1994

Department of PharmaceuticsMember

Vikram Arya, 2003Sassiporn Sarawek 2007Kai Wu 2006 Pattaraporn Vanachayangkul 2008Karin Haug CurrentWan, Sun Current

Department of Plant Pathology

Doctoral DissertationMember

Li-Tzu Li, 1994 Chi-Guang Wu, 1994

Department of Materials Science and Engineering


4

Richard V. Linhart, 1994Kimberly G. Christmas, 2001Fairland Amos 2005Saijit Daosukho 2007Farid Vaghefi 2012Archana Chidambaram current

Masters ThesisJin-Hwan Jeon, 2002Charley Malpass, 2001

Department of Chemistry


Scott Whipps 1996Isa Benitez 2004Denise Sharbaugh 2010

RESEARCH FELLOWS:

Dr. Chung-Jen Su, M.d., Ph.D.Dr. D. Ackermann, M.D.Dr. D.J. Kok, Ph.D.Dr. Fouad Atmani, Ph.D.Dr. Sivagnanan Thamilselvan, Ph.D.Dr. Shizuka Iida, M.D., Ph.D.Dr. Manbu Moriyama, M.D., Ph.D.Dr. Tohru Umekawa, M.D., Ph.D.Dr. J. Y. Tsai, M.D., Ph.D.Dr. Kinue Aihara, M.D., Ph.D.Dr. Pouran Habibzadegah-Tari, Ph.D. Dr. Carla Escobar, Ph.D.Dr. Hassan Khaskhali, Ph.D.Dr. Jian Zou Ph.D.Dr. Benjamin K. Canales, M.S., M.D., currentDr. Sunil Joshi, Ph.D., currentDr. Hidenori Tsuji, M.D., Ph.D.

5

DEPARTMENTAL, COLLEGE AND UNIVERSITY ADMINISTRATION AND COMMITTEES:

2010 Member, Senate Infrastructure Policy Council

2009 Member, COM Mentoring Selection Committee

2007-08 Member, IDP M.S. Curriculum Committee

2007-10 Member, Faculty Senate

2007-08 Member, Senate Steering Committee

2007-08 Member, Research Policy Committee

2007-10 Member, Senate Academic Policy Council

2007-08 Chair, Senate Research and Scholarship Policy Council 2006-07 Chair, Senate Honorary Degrees, Distinguished Alumnus Awards and

Memorial Committee2006-07 Member, Senate Research and Scholarship Policy Council

2006-07 Member, Senate Academic Policy Council

2005 Member, Animal Resources and Research Advisory Group

2005 Member, University of Florida Teacher/Scholar of the Year Award Committee

2005 Member, Medical Student Research Program Committee

2004-07 Member, Senate Honorary Degrees Distinguished Alumnus Awards and Memorial Committee

2004-08 Member, Senate Research and Scholarship Policy Council

2004-05 Chair, Senate Research and Scholarship Policy Council

2004-05 Member, UF Research Policy Council

2004-06 Member, University of Florida Faculty Senate

2004 Member, Medical Student Research Program Committee

6

2004 Member, Selection Comm for Doctoral Dissertation Advisor/Mentoring Committee

2004 Member, Panel of Judges for Medical Student’s Research Presentations

2004 Member, Selection Comm Research & Graduate Programs Opportunity Fund

2003-05 Member, Graduate Coordinators Advisory Council

2003-06 Member, Faculty Senate Steering Committee

2000-2002 Member, University of Florida Faculty Senate

2000- Member, Departmental Clinical Research Committee

1986- Laboratory Host and Mentor, Annual Student Science Training Program (SSTP), Center for Precollegiate Education and Training, University of Florida

1996- Director, Center for the Study of Lithiasis andPathological Calcification

2000-02 Director, Research and Academic Affairs, Division of Experimental Pathology, Department of Pathology

1998-02 Chief, Division of Experimental Pathology, Department of Pathology

2001 Member, Medical Student Research Committee

2001 Member, Oversight Committee, Medical Education Week

2000-01 Chairman, College Investment Fund (CIF) Grant Review Committee

2000-01 Member, UF Faculty Advisory Committee to Animal Care Services

1999- Member, College of Medicine, Electron Microscopy Committee

1998-02 Member, University of Florida Senate

1997- Member, Department of Pathology Variable CompensationPlan

1997- Member, Advisory Committee to the College of Medicine Associate Dean for Graduate Education

7

1994-2000 Alternate Member, Institutional Review Board

2000 Member, Ad Hoc Committee, Professor’s Salary Increase 1998-01 Chairman, Immunology Faculty Search Committees

1999 Chairman, Selection Committee for College of MedicineFaculty Council Excellence in Basic Science Research Awards

1999 Chairman, Medical Guild Graduate Student Research Competition Committee

1999 Chairman, Selection Committee for University Scholar’s Program

1998-99 Member, Research Committee, Howard Hughes Medical Research Institute Research Resources Program

1998-99 Chairman, Computer Operations Committee, Department of Pathology

1998 Member, Selection Committee for College of MedicineProfessional Excellence Program (PEP) Awards

1998 Member, Selection Committee for College of MedicineTeaching Incentive Program (TIP) Awards

1998 Member, Surgical Pathology Faculty Search Committees

1997 Member, The PhD/MBA subcommittee

1997 Chairman, Selection Committee for College of MedicineFaculty Council Excellence in Research Awards

1995 Member, College of Medicine Diversity Group

1994-98 Pathology Representative, College of Medicine Faculty Council

1993-94 Director, Center for the Study of Inflammatory Host Defense & Tissue Injury

1992-94 Director, Graduate Program, Department of Pathology

1992-94 Member, Department of Pathology Section Chief's Committee

8

1991-94 Departmental Representative, PathologyComparative Pathology Joint Electron Microscopy Facility

1990-99 Member, Department of Pathology Graduate Committee

1989-90 Member, Advisory Committee to the Center forInternational Student and Scholar Services

1989-90 Member, Shand’s Hospital Kidney Stone Center Committee

1989-90 Member, University of Florida Task Force onInternational Students and Visiting Scholars

9

NATIONAL & INTERNATIONAL RESEARCH GRANT AND PROGRAM REVIEW AND ADVISORY COMMITTEES:

2012, Member, NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES, Member Conflict Telephone SEP, ZDK1 GRB-G (M2)

2009-2013 Member, NATIONAL INSTITUTES OF HEALTH, NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES, SPECIAL EMPHASIS PANEL, ZDK1 GRB-G M1 1, The NIDDK-KUH Fellowship Review Committee

2009 Reviewer, NIDDK, Challenge Grants, RFA-OD-09-003

2008 Reviewer, Joint Research Grant under National Research Foundation South Africa/Japan Society for the Promotion of Science

2008 Member, NIDDK Special Emphasis Panel, ZDK1 GRB-6 01 1, George M. O'Brien Urology Research Centers (P50), July 21-22

2008 Member, Urology Overflow Group, ZRG1 RUS-F (02) S, June 17, 2008

2008 Member, Dallas Kidney Stone Program Project Grant Review, ZDK1 GRB-7 (M2), April 10, 2008

2007 Member, Fellowship: Physiology and Pathobiology of Organ System, F10-H 20L, Study Section, March 2007

2006-10 Member, Urologic and Kidney Development and Genitourinary Diseases (UKGD) Study Section

2006 Member, ZRG1 RUS-A 51 1, NIDDK PAR 06 113, October 26-31

2006 Reviewer, Research Grant Management, South African Medical Research Council, Cape Town, South Africa

2006 Member, NIH Center for Scientific Review, ZRG1 EMNR-E (10), Endocrinology, Metabolism, Nutrition and Reproductive Sciences, March 9-10, 2006

2006 External Referee, Innovational Research Incentives Scheme, Netherlands Organization for Health Research and Development, Netherlands

2006 Consultant Reviewer, Health Research Board, Ireland

2005 Chair, NIDDK ZDK1 GRB-9 (J1), Special Emphasis Panel, Nephrolithiasis,

10

November 21, 2005

2004 Member, National Center for Complementary and Alternative Medicine Special Emphasis Panel, ZAT1 DB15, Basic and Preclinal Research, June 7-8.

2003-05 Member, Scientific Review Board, Oxalosis and Hyperoxaluria Foundation,

St Louis, Missouri

2003 Consultant Reviewer, Reviewer, VA Merit Review Application, R. Tyler Miller, Cleveland, Ohio

2002 Member, Center for Scientific Review Special Emphasis Panel, ZRG1 UROL (01), July 9-10

2002 Member, Center for Scientific Review Special Emphasis Panel, ZRG1 UROL (17), Small Business: Urology, July 10

2002 Assessor (Reviewer), Grant PolyU 5265/02M, Research Grants Council, University Grants Committee, Hong Kong, China

2001 Member, Special Emphasis Panel CSR/NIH SSS-T-10B Study Section, Endocrine and Reproductive Sciences and Nutritional and Metabolic Sciences Integrated Review Groups, November 8

2001 Reviewer, Masters of Science Program in the Department of Pathology, College of Medicine, Kuwait University, Kuwait, May 18-22rd 2001

2001 Reviewer, VA Merit Review Application, Dr. Neil S. Mandel, Professor of Medicine, Biophysics, Biochemistry, Orthopedic Surgery, Medical College of Wisconsin, Associate Dean for VA Research and Associate Chief of Staff for research, Zablocki VA Medical Center, Milwaukee, Wisconsin.

2001 Reviewer, VA Merit Review Application, Dr. Jeff A. Wesson, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin

2001 Assessor (Reviewer), Grant PolyU 5280/01M, Research Grants Council, University Grants Committee, Hong Kong, China

2000 Reviewer, Travelling Research Fellowship Application, The Wellcome TrustLondon, England

2000-04 Consultant, Program Project on Kidney Stones, University of Chicago, Chicago

11

1999 Reviewer, Stone Grant, St. Peters Trust, London, England

1999 Member, Review Comm, National Institute of Diabetes and Digestive andKidney Diseases, RFA: DK-98-018 “Urology Research Centers”,March 25-26, Baltimore, Maryland

1998 Reviewer, Kidney Stone Grant, The Division of Biology and Medicine,Swiss National Science Foundation, Berne, Switzerland

1998 Member, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Special Emphasis Panel Review Committee, University of Texas Southwestern Medical Center Program Project Application, Formulation of Rational Therapy of Nephrolithiasis (Dr. Charles Y.C. Pak, PI)

1996-1999 Member, National Institutes of Health (NIH) Urology Special Emphasis Panel Study Section

1996-00 Member, Scientific Review Board, Oxalosis and Hyperoxaluria Foundation,St Louis, Missouri

1995-97 Member, National Institutes of Health (NIH) General Medicine - B StudySection

1995-1999 Member, Advisory Group, O’Brien Center on Kidney Stones, University of Chicago, Chicago

1990-95 NIH, Ad-hoc Reviewer on Urinary Stone Grants

1990-91 Veteran’s Administration, Reviewer on Urinary Stone Grants

1990-92 Member, NIDDK Special Grants Review Committees, University of ChicagoProgram Project Application, Pathogenesis and Treatment of Calcium Nephrolithiasis (Dr. Frederic L. Coe, PI).

12

ORGANIZATIONAL EXPERIENCE:

2008-2012 Member, Scientific Advisory Board, 12th International Symposium on Urolithiasis, May 9-12, 20012, Ouro Preto, Brazil

2007-08 Member, International Scientific Committee, World Congress of Nephrology Satellite symposium, Bone, Stone and Kidney, April 26-28, Rio de Janeiro, Brazil

2008-09 Member, Scientific Committee, 12th European Symposium on Urolithiasis, October 15-17, Lake Como, Italy

2006-7 Member, Scientific Committee, 12th European Symposium on Urolithiasis, July 4-7, 2007, Lisbon, Portugal

2004-08 Member, International Organizing Committee, International Symposium on Urolithiasis, Niece, France, to be held 2008

2004 Member, International Advisory Committee, 7th International Workshop on Primary Hyperoxaluria, October 8-10, Mayo Clinic, Rochester

2006 Chair, Nominating Committee, Society for Leukocyte Biology

2004-7 Member, Nominating Committee, Society for Leukocyte Biology

2004 Member, International Organizing Committee, International Symposium on Urolithiasis, Hong Kong, May 24-28, 2004

2003-04 Member, Graduate Coordinators Advisory Council

2004-05 Chair, Faculty Senate Research and Scholarship Policy Council

2002-03 Chair, Faculty Senate Nominating Committee

2002-03 Chair, Faculty Academic Advisory Council

2000-2001 Past President, Faculty Council, College of Medicine

1999-00 President, Faculty Council, College of Medicine

1997-00 Member, International Organizing Committee, International Symposium on Urolithiasis held February 13-17, 2000; Cape Town, South Africa

13

1999 Organizer, 2nd Finlayson Colloquium on Urolithiasis, January 28-31st, Gainesville, Florida

1998-99 President-elect, Faculty Council, College of Medicine

1997-99 President, Society for Research on Calculus Kinetics (The ROCK society)

1997-98 Vice President, Faculty Council, College of Medicine

1993-95 Secretary-Treasurer, The ROCK society

1993-94 President, Florida Society for Microscopy

1992-93 President Elect, Florida Society for Microscopy

1989-90 Director-at-Large, Biological Sciences, Florida Society for Electron Microscopy

1991 Member, Organizing Committee, Joint Meeting of Florida Society for Electron Microscopy, Alabama Society for Electron Microscopy and Southeastern Electron Microscopy Society Gainesville, April 1st - April 4th.

1990 Member, Organizing Committee, Finlayson Colloquium on Urolithiasis,Held at University of Florida April 22-24

1985 Member, Local Arrangements Committee, Annual Meeting of the

Mycological Society of America.

1988-89 President, Florida Society for Electron Microscopy

1987-88 President Elect, Florida Society for Electron Microscopy

1986-87 Vice President, Florida Society for Electron Microscopy

1986 Vice-Chairman, Gordon Conference on Calcium Oxalate

1984-86,89-90,93 Faculty Advisor, Muslim Students Association, University of Florida

1984-1994 Member Organizing Committee, Symposium on Stones and Crystals in Disease, Annual Meetings of the Scanning Microscopy International

1973 Chairman, Council of International Organizations, University ofFlorida

14

1972 President, International Club, University of Florida

1971 Secretary, International Club, University of Florida

1964-66 Coach, Cricket Team, Government College, D.I. Khan, Pakistan

1961 Secretary, Biological Association, Reza Degree College,Rampur, India

15

EDITORIAL AND JOURNAL REVIEW EXPERIENCE:

2010- Member, International Advisory Board, Kuwait Journal of Science and Engineering, Academic Publication Council, University of Kuwait, Kuwait

2004- Member, American Urological Association UrolithiasisAbstract Review Team

2008 Member, American Society of Nephrology Mineral MetabolismAbstract Review Team

2007- Member, Editorial Board, Nephron Experimental Nephrology

2004- Associate Editor, Urological Research

2003-04 Member, Editorial Board, Urological Research

2002-04 Managing Editor, Frontiers in Bioscience

2000 Co-Editor, Proceedings of the 9th International Symposium on Urolithiasis,University of Cape Town, Rondebosch, Cape Town, South Africa

1999 Co-Guest Editor, Kidney Stones: Recent Research and Management Concepts, J Eondourology 13 (9)

1999 Guest Editor, J Am Soc Nephrol Supplement 10, Proceedings of The 2nd Finlayson Symposium

1997-2000 Member, Editorial BoardJournal of Urology, Investigative Urology Section,

1996 Guest Editor, Stones and Crystals, Scanning Microscopy 10 (2), 303-612

1995 Member, American Society of Nephrology Mineral MetabolismAbstract Review Team

1984-98 Member, Editorial Board,Scanning Microscopy

1994- Member, Editorial Board,Italian Journal of Mineral and Electrolyte Metabolism

1991 Guest Editor,Proceedings of Finlayson Colloquium

16

Urolithiasis, Journal of Kidney Diseases,Vol. 17, April 1991

1982- Ad-hoc Reviewer

1. Journal of Urology,2. Scanning Microscopy3. Cell and Materials4. Kidney International5. American Journal of Physiology6. Clinical Chemistry7. J. Clinical Chemistry8. J. Clinical Investigation9. J. Crystal Growth10. J. Nutritional Biochemistry11. J. Endourology12. J. Bone and Min Research13. Protein Science14. Urology15. Nephrol, Dialysis, Transplantation16. Am J Kid Diseases17. J Am Soc Nephrol18. Clin Chem & Lab Med19. Planta Medica20. Experimental Biology and Medicine 21. African Journal of Biotechnology

17

INVITED STATE OF THE ART AND PLENARY LECTURES:

77. May 12, 2012, Stress Oxidative: Urolithiasis and Chronic Kidney Disease, 12th International Symposium on Urolithiasis, Ouro Preto, Brazil

76. May 11, 2012, Crystal and cells, a Review. 12th International Symposium on Urolithiasis, Ouro Preto, Brazil

75. May 9, 2012. Plenary Debate, Basic Science Research of the Past 25 years: Prognosis for Stone Treatment - Promising, 12th International Symposium on Urolithiasis, Ouro Preto, Brazil

74. February 24-28, 2012, 27th Annual Meeting of the European Association of Urology, Paris, France, Meeting of the EAU Section of Urolithiasis (EULIS): Urolithiasis - new insights in pathophysiology - challenges in education - trends in treatment

73. September 8, 2011, The association of stone disease with chronic kidney disease, diabetes

and hypertension, is oxidative stress a common link? 1st Metting of European Association of Urology Section of Urolithiasis (EULIS), London, United Kingdom.

72. September 7, 2011, Of Mice and men, what do animal model studies reveal about pathogenesis of kidney stones? 1st Metting of European Association of Urology Section of Urolithiasis (EULIS), London, United Kingdom.

71. September 12, 2010, Hypertension and nephrolithiasis. 25th Brazilian Nephrology Meeting, Vitorai, Brazil.

70. September 14, 2010, Reactive Oxygen species (oxidative stress) and calcium oxalate nephrolithiasis. 25th Brazilian Nephrology Meeting, Vitorai, Brazil.

69. July 21, 2010, Renal oxidative stress in stone disease, evidence from animal model and tissue culture studies. Nephrology Research Conference, Medical College of Wisconsin, Milwaukee, Wisconsin

68. February 14, 2010, Genetic Basis of Renal Cellular Dysfunction and the Formation of Kidney

Stones, University of Florida Department of Urology, CME Seminar, Ponte Vedra, Florida

67. December 3, 2009, Nephrocalcinosis in Animal Models with or without Stones, 3rd International Urolithiasis Symposium and Indiana University School of Medicine, Continuing Medical Education Seminar, Indianapolis, Indiana

66. October 16, 2009, Crystal/Cell Interaction : Oxidative Stress and Nephrolithiasis, 6th Eurolithiasis Society Symposium and 16th European Symposium on Urolithiasis, Como, Italy

18

65. June 12, 2009, Herbal Medicines in the Management of Urolithiasis: Alternative or Complementary? 7th Symposium, New Developments in Clinical Pharmacy and Clinical Pharmacology; Stresa, Italy

64. October 25, 2008, Cellular Dysfunction and kidney stones, SIUT 6th International Symposium of Urology, Nephrology and Transplantation, Karachi, Pakistan

63. October 24, 2008, Alternative medicine for kidney stones, SIUT 6th International Symposium of Urology, Nephrology and Transplantation, Karachi, Pakistan

62. September 4, 2008, Crystal-Cell interaction: Reactive oxygen species, oxidative stress and nephrolithiasis, 11th International Symposium on Urolithiasis, Nice, France

61. April 26, 2008, Crystal Induced Inflammation, 2nd Annual Urology Research Retreat, Urology

Department, College of Medicine, UF

60. November 7, 2007, Calcium Oxalate Nephrolithiasis: Animal Models, Urology Grand Rounds, Urology Department, College of Medicine, UF.

59. October 5, 2007, Investigations of Nephrolithiasis: Animal Model Studies, Urology Grand Rounds, University of Colorado Health Sciences Center, Denver, Colorado.

58. Aug 25th, 2007, Calcium Oxalate/Calcium Phosphate Association in Kidney Stones, Results of Experimental Studies, State of the Art Lecture, 17th Annual Meeting of the Japanese Society on Urolithiasis Research, Kurume , Japan

57. Aug 21st, 2007, Hypercalciuric Mice, Special Lecture, Urolithiasis Mini-Forum, Kanazawa Medical University, Uchinada, Ishikawa, Japan

56. July 6th, 2007, What did we learn yesterday? Highlights of Presentations, 5th eUlis Symposium, Lisbon, Portugal

55. July 6th, 2007, Research Methods on Stone Disease, Round Table on Research Methods, 5th eUlis Symposium, Lisbon, Portugal

54. April 28, 2007, Invited Lecture, Crystal Attachment and Stone Formation, Bone, Stone and the Kidney, World Congress of Nephrology Satellite Symposium, Rio de Janeiro, Brazil.

53. May 26, 2006, Invited Lecture, Role of Injury and Inflammation in Urolithiasis, ROCK Society Meeting at the Annual American Urological Association Meeting IN Atlanta.

52. April 12, 2006, Surgical Grand Rounds, Agha Khan University Medical College, Karachi, Pakistan

19

51. April 10, 2006, Guest Lecture, Cell Injury/Dysfunction Critical for Stone Formation, Sindh Institute of Urology and Transplantation, Dow Medical College, Karachi, Pakistan

50. April 6, 2006, Visiting Professor, Renal Tubular Damage/Dysfunction Key to the Formation of Kidney Stones, International Center for Chemical Scineces, University of Karachi, Pakistan

49. April 1, 2006, Seminar, Kidney Stone Microstructure, Studies of Biological Sciences, University of the Punjab, Lahore, Pakistan

48. March 28, 2006, Visiting Professor, Micromorphology of Kidney Stones, International Center for Chemical Scineces, University of Karachi, Pakistan

47. July 19th, 2005, State of the Art Lecture, Tissue injury induced by oxalate. FASEB Summer Research Conference, Calcium Oxalate in Biological Systems, Tucson, Arizona

46. June 16th, 2005, Discussant, Debate: The key to Stone formation is, Renal tubular

dysfunction. 11th European Urolithiasis Symposium, Coburg, Germany.

45. February 25, 2005, Keynote Address, Urolithiasis Research – Past, Present and Future. SIUT (Sind Institute of Urology and Transplantation) Urolithiasis Symposium, Karachi University, Pakistan

44. February 25, 2005, Plenary Lecture, Crystal-induced renal inflammation. SIUT Urolithiasis Symposium, Karachi University, Pakistan

43. February 26, 2005, Plenary Lecture, Animal Models of CaOx nephrolithiasis. SIUT Urolithiasis Symposium, Karachi University, Pakistan

42. October 8, 2004, State of the Art Lecture, Oxalate-induced oxidative stress in the kidneys, 7th International Workshop on Primary Hyperoxaluria, Mayo Clinic, Rochester, MN

41. July 8, 2004, State of the Art Lecture Animal Models Calcium Oxalate Nephrolithiasis. Ixion Biotechnology, Alachua, Florida

40. May 28, 2004, State of the Art Lecture, Animal Models of the Calcium Oxalate Nephrolithiasis. 10th International Symposium on Urolithiasis, Hong Kong, May 25-28,

39. December 1-15, 2003, Visiting Professor, Sindh Institute of Urology and Transplantation, Dow Medical College, Karachi, Pakistan

38. November 20, 2003, Plenary Lecture, Mediators of Oxalate Induced Tissue Injury, Oxalosis and Hyperoxaluria Meeting sponsored by National Institutes of Health, Annapolis, Maryland

20

37. October 24, 2003, Invited Lecture, Crystal Cell Interaction: Cellular Involvement in Stone Disease, Department of Urology, Nagoya City University, Nagoya, Japan

36. October 24, 2003, Keynote Address Special Lecture, Crystal-Induced Inflammation of the Kidneys: Results from Tissue Culture and Animal Model Studies, 33rd Western Regional Meeting of the Japanese Society of Nephrology, Nagoya, Japan.

35. June 11, 2003, State of the Art Lecture, Organic Matrix of Kidney Stones: Its role in the pathogenesis of urolithiasis, 10th European Symposium on Urolithiasis, Istanbul, June 11-14

34. June 11, 2003, State of the Art Lecture, Crystal Cell Interaction: Cellular involvement in stone disease, 10th European Symposium on Urolithiasis, Istanbul, June 11-14

33. June 12, 2003, State of the Art Lecture, Stone research on the bench: where we are and where we are going?, 10th European Symposium on Urolithiasis, Istanbul, June 11-14

32. June 14, 2003, Take Home Message, Pathophysiology / Etiology, 10th European Symposium on Urolithiasis, Istanbul, June 11-14

31. May 28, 2002, First Annual Birdwell Finalyson Memorial Lecture, ROCK Society meeting at

the annual meeting of the American Urological Association, Orlando, Florida, , Stone Research on the Bench: where we are and where we are going”

30. April 5-6, 2002, Invited Lecture, 6th European Workshop on Hyperoxaluria, Hannover, Germany.

29. July 3-5, 2001, Member, Biochemistry of Stone Disease Committee, 1st International Consultation on Stone Disease, Organized by Am Urol Assoc, Con Am Urol, Eur Assoc Urol, Urol Asssc Asia, Soc Endourol, WHO, Intl Consul Urol Dis, Intl Soc Urol, Palais des Congress, Paris, France.

28. April 28th-29th , 2001, 4th Biennial Conference of Pakistan Society of Nephrology, Avari Hotel, Lahore, Pakistan.

State of the Art Lecture: New Trends in Renal Stone Research

27. April 10th -14th , 2001, 1st International and 11th National Chemistry Conference, Peshawar University, Peshawar, Pakistan

Plenary Lecture: Nucleation of Calcium Oxalate

26. November 16-17, 2000, Oxalosis and Calcium Oxalate Stone Disease, Workshop organized by National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH.

21

State of the Art Invited Presentation: Animal Model of Hyperoxaluria, Experimental Induction

25. February 17, 2000, Invited Overview lecture, Crystal-cell Interaction, The backbone of stone formation, Urolithiasis 2000, 9th International Symposiumon Urolithiasis, Cape Town, South Africa.

24. November 30, 1999, Symposium on Mineralization in Natural and Synthetic Biomaterials,Fall Meeting of the Materials Research Society, Boston, Mass.

Invited Lecture: Involvement of Cellular Membranes and Their Lipids in Nucleation of Stone Forming Crystals.

23. November 29, 1999, Department of Physiology, University of Massachusetts College of Medicine, Worcester, Mass.

Seminar: Renal Epithelial Injury and Nephrolithiasis

22. August 18, 1999, FASEB Summer Research Conference, Calcium Oxalate in Biological Systems, Copper Mountain, Colorado

Invited Lecture: Cell culture and animal models in the study of nephrolithiasis

21. June 9-12, 1999, 8th European Symposium on Urolithiasis, Parma, Italy

State of the Art Lecture: Calcium Oxalate Stone Formation as an Example of Biomineralization

20. May 28-29, 1999, 1st Istanbul Urolithiasis Symposium, Istanbul, Turkey

State of the Art Lectures1. Inhibitors and Promoters of Stone Growth 2. Calcium Oxalate Crystals are Injurious to renal Epithelial Cells: Results of Studies in Rat Model of Hyperoxaluria

19. April 12-15, 1999, Keynote Address, 87th Annual Meeting of the Japanese Urological Association, Osaka, Japan

Pathogenesis of Urolithiasis: Results of Experimental Studies

18. March 12-13, 1999, 5th Workshop on Primary Hyperoxaluria, Kappel, Switzerland

Renal Epithelial Cells are Provoked by Exposure to both Oxalate and Calcium Oxalate

22

Crystals: Results of studies in a rat model of nephrolithiasis

17. December 8-9, 1998, Workshop on New Horizons in the Pathogenesis,Treatment & Cure of Hyperoxaluria, Oxalosis & Oxalate Stone Diseases, Sponsored by The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland

State of the Art Lecture, Oxalate and Calcium Oxalate Crystals Provoke Renal Epithelial Cells: Results of Studies in rat Models

16. August 29, 1998, Keynote Address Special Lecture, Annual Meeting of the Urological Association of the Republic of China, Taipei, Taiwan

Oxalate Induced Responses of Renal Epithelial Cells

15. April 13, 1998, Hospital For Special Surgery, New York, Metabolic Bone Disease Conference

Seminar: Crystal Cell Interaction and Calcium Oxalate Nephrolithiasis

14. January 27, 1997, MARC/MBRS Guest Lecture Series, School of Natural and Health Sciences, Barry University, Barry University,Miami

Seminar: “Kidney Stone Formation”

13. November 21, 1996. NIDDK, The Division of Kidney, Urologic and HematologicDiseases, NIH Campus, Bethesda, Maryland

Seminar: Calcium Oxalate Crystal-Renal Epithelial Cell Interaction and Kidney Stone Formation

12. June 8-10, 1995. Sixth European Symposium on Urolithiasis, Stockholm, Sweden

Invited Speaker Round Table Discussion“What happens in the nephron in calcium oxalate stone disease”

11. August 21-26, 1994, Mineral Scale Formation and Inhibition, Symposium in honor of Prof. George H. Nancollas, American Chemical Society Meeting, Washington, D.C.

Invited Speaker,“Role of Calcium Phosphate in Calcium Oxalate Crystallization in vivo”

10. April 21st-23rd, 1994, 5th European Urolithiasis Symposium, Manchester, England

23

Invited Speaker Round Table Discussions on:1. Methods of Crystallization Studies 2. Site and Mechanism of Stone Initiation

9. October 4-5, 1993, Urolithiasis: State of the art and future research needs, Sponsored by the Division of Kidney, Urologic and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland

State of the Art: Basic research

8. December 27-29, 1993, 7th National Conference of Urolithiasis Society of India,Madras, India

Keynote Address Oration Lecture: "Nephrolithiasis: A free or fixed particle disease."

7. April 14, 1993, Symposium on hydroxyapatite and related materials, Spring meeting ofMaterials Research Society, San FranciscoTitle: Pathological Crystallization of calcium oxalate and calcium phosphate."

6. April 1-3, 1993, 4th European Symposium on Urolithiasis, Tubingen, Germany

Title: "Cellular membranes as heterogeneous nucleator of calcium oxalate crystals."

5. April 5, 1993, University Hospital, Marburg, Germany

Title: "Formation and retention of calcium oxalate crystals in the renal tubules."

4. March 31, 1993, Faculty of Medicine and University Policlinic, Inselspital, Berne,Switzerland

Title: "Formation and retention of calcium oxalate crystals in the renal tubules."

3. August 23-27, 1992, 7th International Symposium on Urolithiasis, Cairns, AustraliaCo-chairperson, Theme Poster Session on "Stone Composition: Matrix and Membranes."

Plenary Lecture: "Renal epithelial injury: a risk factor in urolithiasis."

2. April 30th, 1992, Symposium on Pathogenesis, diagnosis and therapy of nephrolithiasis,Ospedale S. Maria della Misericordia, Udine, Italy

Title: "Ultrastructural morphology of calcium oxalate crystal deposition in kidneys."

1. October 18, 1991, Department of Nephrology, Institute of Internal Medicine and Institute of Urology, University of Padova, Italy

24

Title: "Renal epithelial injury, cell membrane and crystallization of calcium oxalate."

25

SESSION CHAIRMANSHIPS:

May 11, 2012, Moderator, Mini-Conferences, 12th International Symposium on Urolithiasis, Ouro Preto, Brazil

May 10, 2012, Moderator, Oral Presentations-Pediatric Stones, 12th International Symposium on Urolithiasis, Ouro Preto, Brazil

September 9, 2011, Co-Chair, Stones in animals/ Clinical Therapy in humans. Ist Meeting of European Association of Urology Section of Urolithiasis (EULIS), London, United Kingdom

April 29, 2009, Moderator, Poster Session, Stone Disease: Research/New Technology (1), Annual Meeting of American Urological Association, Chicago

October 24, 2008, Session Chair, Urology, SIUT 6th International Symposium of Urology, Nephrology and Transplantation, Karachi, Pakistan

September 4, 2008, Session Chair, Crystal and cells, 11th International Symposium on Urolithiasis, Nice, France

July 10, 2007, Session Chair, 5th European Urolithiasis Symposium, Lisbon, Portugal

July 19th, 2005, Session Chair, Oxalate Chemistry and Biology, FASEB Summer Research Conference, Calcium Oxalate in Biological Systems, Tucson, Arizona

June 17th, 2005, Chair, Session on Crystallization, Renal Tubules, 11th European Urolithiasis Symposium, Coburg, Germany.

April 30th, 2005, Moderator, Session 4, Annual Meeting of the ROCK (Research on Calculus Kinetics) Society, Chicago, IL.

June 11, 2003, Session Chair, Hyperoxaluria and Related Disorders, 10th European Symposium on Urolithiasis, Istanbul, Turkey.

August 6, 2002, Session Chair, Crystal-Cell Interactions, 2002 FASEB Summer Research Conferences, Calcium Oxalate in Biological Systems, August 3-8, Vermont Academy, Saxtons river, Vermont.

February 16, 2000, Co-Chair, Crystallization Modulators and Macromolecules,Urolithiasis 2000, 9th International Symposium on Urolithiasis, Cape Town, South Africa.

June 9-12, 1999, Co-Chair: Session on Inhibitors and Promoters, 8th European Symposium on Urolithiasis, Parma, Italy.

26

March 12-13, 1999, Co-Chair: Session on Diagnostic Approaches, 5th Workshop on Primary Hyperoxaluria, Kappel, Switzerland.

May 22, 1997, Chairperson, Crystallization Processes, 7th European Symposium on Urolithiasis,Paris, France.

April 12, 1997, Moderator, Basic Research, Annual Meeting of American Urological Association, Special Session on Stone Disease sponsored by the R.O.C.K. Society, San Antonio, Texas.

December 27-29, 1993, Co-Chair, Pathogenesis of renal calculi, 7th National Conference of Urolithiasis Society of India, Madras, India.

April 1-3, 1993, Co-Chair, Session on Calcium metabolism and related problems, 4th European Symposium on Urolithiasis, Tubingen, Germany

27

HONORS & AWARDS:

2011 MARQUIS Who's Who in America, 66th Edition

2010 Fellow of the American Society of Nphrology

2006 Fellow of the American Society of Nephrology

2001 University of Florida Research Foundation Professor

1997 University of Florida College of Medicine, Award for Excellence in Research, Faculty Research Prize in Basic Science

1997 Best Poster in Basic Science Research, 97th Annual Meeting of The American Urological Association, New Orleans, April 16, 1997.

1993 MARQUIS Who's Who in Science and Engineering

1993 Oration Lecture, 7th National Meeting of the Urolithiasis Society of India, Madras, India

1993 Invited Speaker, State of the Art: Basic Research.Urolithiasis: State of the Art and Future Needs, Sponsored by the Division of Kidney, Urologic and Hematologic Diseases, NIDDK, NIH

1992 University of Florida Research Achievement Award

1974- University Research Fellowship, 1976, University of Adelaide, Australia1973 Admitted to Academic Honorary Society, Phi Kappa Phi

1972 Admitted to Leadership Honorary Society, Omicron Delta Kappa

1972 Admitted to Scientific Honorary Society, Sigma Xi

1970-73 Fulbright-Hays Scholar, University of Florida, Gainesville

1964 Graduated with Honors from University of Peshawar, Pakistan

1963 Highest Grade in M.Sc. Part I. University of Peshawar, Pakistan

28

CURRENT AND PAST MEMBERSHIP IN PROFESSIONAL SOCIETIES:

American Society for Investigative Pathology

American Society of Nephrology

American Urological Association

The American Society for Bone and Mineral Research

The Society for Basic Urologic Research

New York Academy of Sciences

Society for Biomaterials

Florida Society for Microscopy

Microscopy Society of America

Histochemical Society

29

RESEARCH GRANTS:Active:

2012-2016 Principal Investigator with Dr. Laurie Gower (contact)NIH, RO1DK092311-01A1An in vitro model for studying the role of acidic proteins in Randall’s Plaque and Stone Formation

2009-013 Principal investigatorNIH, RO1Crystal Associated Renal Inflammation and Treatment Options

Submitted:

2012 Co-Principal Investigator with Dr. Johannes W.G. ViewegNIH, T32 DK 094789Training Program in Urologic Research

Completed:

2005-2010 Principal InvestigatorNIH, RO1Calcium Phosphate crystals responsible for idiopathic nephrolithiasis

2005-2007 Co-Principal InvestigatorNIH, R21Oxalobacter as a therapy in IBD-associated urolithiasis

2001-2005 Co-Principal Investigator, Bioengineering Research Partnership withCollege of EngineeringNIH RO1 DK59765Role of Bioplymer and Lipids in Kidney Stone Formation

2000-2005 Principal InvestigatorNIH RO1DK 53962Tissue-Crystal Interaction in Calcium Oxalate Neophrolithiasis

1997-2001 Co-Principal Investigator NIH RO1 DK53556Regulation of Enteric Hyperoxaluria by Oxalobacter

2000-2003 Co-Principal Investigator,NIH RO1DK56249Urolithiasis and Peroxidative Injury

1996-2001 Principal Investigator,NIH RO1 DK 41434

30

Role of Lipids in Urolithiasis

1999 Principal Investigator,NIH R13 DK 547612nd Finlayson Colloquium on Urolithiasis

1996-97 Director, Program Project on Biophysics of Urolithiasis, NIH 5PO1 DK 20586

1997-00 Pathology Core LaboratoryNIH #A1-37281Malaria-Associated Lactic Acidosis/DCA Trial inAfrica (P.W. Stacpoole, PI)

1992-97 Principal Investigator, Project 2Program Project on UrolithiasisNIH 5PO1 DK 20586

1992-97 Principal Investigator, Analytical CoreProgram ProjectNIH 5PO1 DK 20586 Urolithiasis

1991-95 Principal InvestigatorNIH #RO1 DK 41434Role of Lipids in Urolithiasis

1990 Principal InvestigatorUniversity of Florida Division of Sponsored Research Development Award

1990 Co-Principal Investigator with Dr. WoodardKingston Technologies, Catheter Calcification

1987-1992 Co-Principal Investigator with Dr. HackettNIH program project grant # 5 PO1 DK20586Urolithiasis

1978-1987 Co-Investigator with Drs. Hackett and Finlayson, NIH program project grant # AM20586Urolithiasis

31

1974-1973 University Research FellowshipUniversity of Adelaide,Adelaide, Australia

1970-1973 Fulbright-Hay's ScholarshipUniversity of Florida

32

LIST OF PUBLICATIONS

Refereed Publications 155

Editorials & Review Articles 23

Edited Books, Proceedings, and Journal Issues 6

Book Chapters 19

Non Refereed Publications (Proceedings) 70

Miscellaneous Publications (Abstracts, Letters) 145

Total 419

Refereed Publication:

155. Khan A, Khan SR, Gilani AH, 2012, Studies on the in vitro and in vivo antiurolithic activity of Holarrhena antidysenterica. Urol Res

154. Khan SR, Rodriguez DE, Gower LB, Monga M, 2012, Association of Randall plaque with collagen fibers and membrane vesicles. J Urol 187: 1094-1100.

153. Canales BK, Reyes L, Reinhard MK, Khan SR, Goncalves CG, Meguid MM., 2012, Renal glomerular and tubular injury after gastric bypass in obese rats. Nutrition 28: 76-80.

152. Khan A, Bashir S, Khan SR, Gilani GA, 2011, Antiurolithic activity of Origanum vulgare is mediated through multiple pathways. BMC Complementary Alter Med 11: 96-111.

151. Khan, SR and Canales BK, 2011, Ultrastructural Investigation of Crystal Deposits in Npt2a Knockout Mice: Are They Similar to Human Randall's Plaques? J Urol 186: 1107-13

150. Zuo J, Khan A, Glenton PA, Khan SR, 2011. Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-proline-induced hyperoxaluria in the male Sprague-Dawley rats. Nephrology Dialysis Transplantation 26: 1785-1796

149. Khan SR, Glenton PA, 2011. Experimentally induced hyperoxaluria in MCP-1 null mice. Urol Res. 39: 253-258

33

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Meguid%20MM%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Goncalves%20CG%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Khan%20SR%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Reinhard%20MK%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Reyes%20L%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Canales%20BK%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed/22622371

http://www.ncbi.nlm.nih.gov/pubmed/22622371

148. Khan SR, Khan A, Byer K, 2011, Temporal changes in the expression of mRNA of NADPH oxidase subunits in renal epithelial cells exposed to oxalate or calcium oxalate crystals. Nephrology Dialysis Transplantation 26: 1778-1785

147. Vanachayangkul P, Chow N, Khan SR, Butterweck V, 2010, Prevention of renal crystal deposition by an extract of Ammi visnaga L. and its constituents khellin and visnagin in hyperoxaluric rats. Urol Res 39: 189-195

146. Yan Liu, Lan Mo, David S. Goldfarb, Andrew P. Evan, Fengxia Liang, Khan SR, John C. Lieske and Xue-Ru Wu1, 2010, Progressive Renal Papillary Calcification and Ureteral Stone Formation in Mice Deficient for Tamm-Horsfall Protein, American Journal of Physiology (Renal Physiology) 299: F469-478

145. Khan SR, Glenton, PA, 2010, Experimental induction of calcium oxalate nephrolithiasis in mice. J Urol., 184: 1189-1196

144. Bashir S, Gilani AH, Siddiqui AA, Pervez S, Khan SR, Sarfaraz NJ, Shah AJ., 2010, Berberis vulgaris root bark extract prevents hyperoxaluria induced urolithiasis in rats. Phytotherapy Res, 24:1250-1255

143. Vanachayangkul P, Byer K, Khan SR, Butterweck V, 2009, An aqueous extract of Ammi visnaga fruits and its constituents khellin and visnagin prevent cell damage caused by oxalate in renal epithelial cells. Phytomedicine 17:653-658

142. Umekawa T, Tsuji H, Uemura H, Khan SR, 2009, Superoxide from NADPH oxidase as second messenger for the expression of osteopontin and monocyte chemoattractant protein-1 in renal epithelial cells exposed to calcium oxalate crystals. BJU International 104:115-120.

141. Khaskhali MH, Byer KJ, Khan SR, 2008, The effect of calcium on calcium oxalate monohydrate crystal-induced renal epithelial injury. Urol Res 37:1-6

140. Amos AF, Dai L, Kumar R, Khan SR, Gower LB, 2008, Mechanism of formation of concentrically laminated spherules: implication to Randall's plaque and stone formation. Urol Res 37:11-17

139. Yakov I. Rabinovich, Saijit Daosukho, Karen J. Byer, Hassan E. El-Shall , Saeed R. Khan, 2008, Direct AFM measurements of adhesion forces between calcium oxalate monohydrate and kidney epithelial cells in the presence of Ca2+ and Mg2+ ions. Journal of Colloid & Interface Science 352:5053-62

138. Escobar C, Byer KJ, Khaskheli H, Khan SR, 2008, Apatite induced renal epithelial injury: insight into the pathogenesis of kidney stones, J Urol 180:379-387.

34

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Butterweck%20V%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Khan%20S%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Byer%20K%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Vanachayangkul%20P%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Shah%20AJ%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Sarfaraz%20NJ%22%5BAuthor%5D


http://www.ncbi.nlm.nih.gov/pubmed?term=%22Pervez%20S%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Siddiqui%20AA%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Gilani%20AH%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Bashir%20S%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Butterweck%20V%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Khan%20S%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Vanachayangkul%20P%22%5BAuthor%5D

137. Khan SR, Glenton PA, 2008, Calcium oxalate crystal deposition in kidneys of hypercalciuric mice with disrupted type IIa sodium-phosphate cotransporter. Am J Physiol Renal Physiol 294: F1109-1115

136. Yeung LL, Vieweg JW, Khan SR, Robert C. Newman RC and Philipp Dahm P, 2008, A Tribute to the Life and Accomplishments of Birdwell Finlayson, J Urology 179:842-846

135. Khan SR, Glenton PA, Byer KJ, 2007, Dietary Oxalate and Calcium Oxalate Nephrolithiasis. J Urology 178:2191-2196

134. Escobar C, Byer KJ, Khan SR. 2007. Naturally produced crystals obtained from kidney stones are less injurious to renal tubular epithelial cells than synthetic crystals. BJU International 100:891-897.

133. Umekawa T, Iguchi M, Uemura H, Khan SR, 2006, Oxalate ions and calcium oxalate crystal-induced up-regulation of osteopontin and monocyte chemoattractant protein-1 in renal fibroblasts. BJU International 98:656-660.

132. Khan SR, Glenton PA, Byer KJ. 2006, Modeling of hyperoxaluric calcium oxalate nephrolithiasis: Experimental induction of hyperoxaluria by hydroxy-L-proline. Kidney Intl 70:914-923

131. Rabinovich YI, Esayanur M, Daosukho S, Byer K, Khan SR 2006, Adhesion force between calcium oxalate monohydrate crystal and kidney epithelial cells and possible relevance for kidney stone formation. J Colloid Interface Sci. 300: 131-140

130. Habibzadegah-Tari P, Byer K, Khan SR. 2006, Reactive oxygen species mediated calcium oxalate crystal-induced expression of MCP-1 in HK-2 cells. Urol Res 34: 26-36

129. Rabinovich Y, Esaynur M, Daosukho S, Byer K, El-Shall H, Khan S, 2005, Atomic force microscopy measurement of the elastic properties of the kidney epithelial cells. J Colloid and Inteface Science 285:125-135

128. Khan SR, 2005, Hyperoxaluria-induced oxidative stress and antioxidants for renal protection.Urol Res. 33:349-57.

127. Habibzadegah-Tari P, Byer K, Khan SR. 2005, Oxalate induced expression of monocyte chemoattractant protein-1 (MCP-1) in HK-2 cells involves reactive oxygen species. Urol Res. 33:440-7.

126. Delvecchio FC, Brizuela RM, Khan SR, Byer K, Li Z, Zhong P, Preminger GM., 2005, Citrate and vitamin E blunt the shock wave-induced free radical surge in an in vitro cell culture model. Urol Res. 33:448-52

35

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16317535&query_hl=2&itool=pubmed_docsum



125. Umekawa T, Byer K, Uemura H, Khan SR, 2005, Diphenyleneiodium (DPI) reduces oxalate ion- and calcium oxalate monohydrate and brushite crystal-induced upregulation of MCP-1 in NRK 52E cells. Nephrol Dial Transplant. 20:870-878

124. Grewal JS, Tsai JY, Khan SR., 2005, Oxalate-inducible AMBP gene and its regulatory mechanism in renal tubular epithelial cells. Biochem J. 387:609-616.

123. Byer K and Khan SR, 2005, Citrate provides protection against oxalate and calcium oxalate crystal induced oxidative damage to renal epithelium. J Urol. 173: 640-646

122. Umekawa T, Hatanaka Y, Kurita T, Khan SR, 2004, Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys. J Am Soc Nephrol 15: 635-644

121. El-Shall H, Jeon JH, Abdel-Aal EA, Khan S, Gower L, Rabinovich Y, 2004, A study of primary nucleation of calcium oxalate monohydrate: II. Effect of urinary species. Cryst. Res. Technol. 39, No. 3, 222 – 229

120. El-Shall H, Jeon JH, Abdel-Aal EA, Khan S, Gower L, Rabinovich Y, 2004, A study of primary nucleation of calcium oxalate monohydrate: I-Effect of supersaturation. Cryst. Res. Technol. 39, No. 3, 212 – 219

119. Aihara K, Byer KJ, Khan SR 2003, Calcium phosphate induced renal epithelial injury and stone formation: involvement of reactive oxygen species. Kidney Intl 64: 1283-1291.

118. Iida S, Ishimatsu M, Chikama S, Inoue M, Matsuoka K, Akasu T, Noda S, Khan SR, 2003,Protective role of heparin/heparan sulfate on oxalate-induced changes in cell morphology and intracellular Ca(2+). Urol Res 31: 198-206

117. Umekawa T, Chegini N, Khan SR, 2003, Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant. 18:664-9.

116. Thamilselvan S, Khan SR, Menon M, 2003, Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31:3-9.

115. Christmas KG, Gower LB, Khan SR, El-Shall H, 2002, Aggregation and dispersion characteristics of calcium oxalate moonohydrate: effect of urinary species. J Colloid & Interface Science 256: 168-174

114. Khan SR, Glenton PA, Backov R Talham DR, 2002, Presence of lipids in urine, crystals and stones: Implications for the formation of kidney stones. Kidney International 62: 2062-2072.

113. Baggio B, Budakovic A, Pirante G, Gambaro G, Manzato E, Khan SR, 2002, Dietary fatty acid

36

C:\\entrez\\query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15533056

supplementation modulates the urinary excretion of calcium and oxalate in the rat – Insight into calcium lithogenesis. Nephron 91: 486-491.

112. Khan SR, Johnson JM, Peck AB, Cornelius JG, Glenton PA, 2002, Expression of osteopontin in rat kidneys: induction during ethylene glycol induced calcium oxalate nephrolithiasis. J Urol 168: 1173-1181.

111. Umekawa T, Chegini N, Khan SR, 2002, Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney International 61: 105-112.

110. Atmani F, Khan SR, 2002, Quantification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in vitro in the urine of healthy controls and stone-forming patients. Urol Int 68:54-59.

109. Gokhale JA, Glenton PA., Khan SR, 2001, Characterization of Tamm-Horsfall protein in a rat nephrolithiasis model. J Urol 166: 1492-1497.

108. Moriyama MT, Glenton PA, Khan SR, 2001, Expression of Inter--inhibitor related proteins in kidneys and urine of hyperoxaluric rats. J Urol 165: 1687-1692.

107. Fasano JM, Khan SR, 2001, Intratubular crystallization of calcium oxalate in the presence of membrane vesicles: an in vitro study. Kid Intl 59: 169-178.

106. Maslamani S, Glenton PA, Khan SR, 2000, Changes in urine macromolecular composition during processing. J Urol 164: 230-236.

105. Thamilselvan S, Byer KJ, Hackett RL, Khan SR, 2000, Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-assocaited injury to LLC-PK1 and MDCK cells. J Urol 164: 224-229.

104. Backov R, Lee CM, Khan SR, Mingotayud C, Fanucci GE, Talham DR, 2000, Calcium oxalate monohydrate precipitation at phosphatidylglycerol Langmuir monolayers. Langmuir 16: 6013-6019.

103.Atmani F, Khan SR, 2000, Effects of an extract from Herniaria hirsuta on calcium oxalate crystallization in vitro. Brit J Urol 85: 621-625.

102. Khan SR, Maslamani SA, Atmani F, Glenton PA, Opalko FJ, Thamilselvan S, Hammett-Stabler C, 2000, Membranes and their constituents as promoters of calcium oxalate crystal formation in human urine. Calcif Tissue Intl 66, 90-96.

101.Khan SR, Byer KJ, Thamilselvan S, Hackett RL, McCormack WT, Benson NA, Vaughn KL, Erdos G, 1999, Crystal-cell interaction and apoptosis in oxalate-associated injury of renal epithelial cells. J Am Soc Nephrol 10: S457-S463.

37

100. Thamilselvan S, Hackett RL, Khan SR, 1999, Cells of proximal and distal tubular origin respond differently to challenges of oxalate and calcium oxalate crystals. J Am Soc Nephrol 10: S452-456.

99. Iida S, Inoue M, Yoshi S, Yanagaki T, Chikama S, Shimada S, Matsuoka K, Noda S, Khan SR, 1999, Molecular detection of heparan sulfate proteoglycan mRNA in rat kidney during calcium oxalate nephrolithiasis. J Am Soc Nephrol 10: S412-S416. 98. Atmani F, Khan SR, 1999, Role of urinary bikunin in the inhibition of calcium oxalate crystallization. J Am Soc Nephrol 10: S385-388.

97. Backov R, Khan SR, Mingitaud C, Byer K, Lee CM, Talham DR, 1999, Precipitation of calcium oxalate monohydrate at phospholipid monolayers. J Am Soc Nephrol 10: S359-363.

96. Sidhu H, Schmidt ME, Cornelius JG, Thamilselvan S, Khan SR, Hesse A, Peck AB, 1999, Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract dwelling bacterium Oxalobacter frmigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 10: S334-340.

95. Iida S, Peck AB, Byer KJ and Khan, S.R., 1999, Expression of bikunin mRNA in renal epithelial cells after oxalate exposure. J Urol. 162: 1480-1486.

94. Iida S, Peck AB, Johnson-Tardieu J, Moriyama M, Glenton PA, Byer KJ and Khan, S.R., 1999, Temporal changes in mRNA expression for bikunin in the kidneys of rats during calcium oxalate nephrolithiasis. J Am Soc Nephrol .10:986-996.

93. Li DY, Weng Y, Yang BC, Zander DS, Saldeen T, Nichols WW, Khan S, Mehta JL, 1999, Inhibition of arterial thrombus formation by Apo-A-1-Milano. Arteriosclerosis, Thrombosis and Vascular Biology (In press).

92. Atmani, F.and Khan, S.R., 1999, Role of inter-alpha-inhibitor and its related proteins in urolithiasis, I. Purification of an inter-alpha-inhibitor related protein from the bovine kidneys. Urological Research 27: 57-61.

91. Atmani, F., Glenton, PA and Khan, S.R., 1999, Role of inter-alpha-inhibitor and its related proteins in experimentally induced calcium oxalate urolithiasis, II. Localization of proteins and expression of bikunin gene in rat kidneys. Urological Research 27: 63-67.

90. Thamilselvan S, Khan SR, 1998, Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies. J Nephrology 11S: 66-69.

89. Whipps, S, Khan, SR, Opalko FJ, Backov R and Talham DR, 1998, Growth of calcium oxalate monohydrate at phospholipid Langmuir monolayers. J Crystal Growth 192: 243-249.

38

88. Atmani, F., Glenton, PA and Khan, S.R., 1998, Identification of proteins isolated from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects. Urological Research 26: 201-207.

87. Habeger CF, Condon CE, Khan SR, Adair JH, 1997, Evaluation of the calcium oxalate monohydrate Hamaker constant based on static dielectric constant determination and electronic polarization. Colloids and Surfaces B: Biointerfaces 10: 13-21.

86. Gokhale, J.A., Glenton, P.A., Khan, S.R., 1997, Biochemical and quantitative analysis of Tamm Horsfall protein in rats. Urol Res 25(5): 347-354.

85. Opalko FJ, Adair JH, Khan SR, 1997, Heterogeneous nucleation of calcium oxalate trihydrate in artificial urine by constant composition. J Crystal Growth 181(4):410-417, 1997.

84. Thamilselvan S, Hackett RL, Khan SR, 1997, Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol, 157: 1059-1063.

83. Khan SR, 1997, Calcium phosphate/calcium oxalate crystal association in urinary stones: implications for heterogeneous nucleation of calcium oxalate. J Urol 157:376-383.

82. Atmani, F., Mizon J. and Khan, S.R., 1996, Inter-alpha-inhibitor: a protein family involved in the inhibition of calcium oxalate crystallization. Scann Micros 10: 425-434, 1996

81. Khan SR, Atmani F, Glenton P, Hou Z-C, Talham DR, Khurshid M, 1996, Lipids and membranes in the organic matrix of urinary calcific crystals and stones. Calcif Tisssue Int 59:357-365.

80. Gokhale, J.A., McKee M.D., Khan, S.R., 1996, Immunocytochemical localization of Tamm-Horsfall protein in the kidneys of normal and nephrolithic rats. Urol Res 24:201-209.

79. Gokhale, J.A., Glenton, P.A., Khan, S.R., 1996, Localization of Tamm-Horsfall protein and osteopontin in a rat nephrolithiasis model. Nephron 73:456-461.

78. Atmani, F., Mizon J. and Khan, S.R., 1996, Identification of uronic-acid-rich protein as urinary bikunin, a light cahin of inter-(-inhibitor. Eur J Biochem 236:984-990.77. Atmani, F., Opalko F.J. and Khan, S.R., 1996, Association of urinary macromolecules with calcium oxalate crystals induced in vitro in normal human and rat urine. Urol Res 24:45-50.

76. Mehta A, Yang BC, Khan S, Hendricks J, Stephen C, Mehta JL, 1995, Oxidized low density lipoproteins facilitate leukocyte adhesion to aortic intima without affecting endothelium-dependent relaxation: Role of P-selectin. Atherosclerosis, Thrombosis and Vascular Biology 15:2076-2083.

75. Khan SR and Glenton, P.A., 1996, Increased urinary excretion of lipids by patients with kidney

39

stones. British J Urol 77: 506-511. 74. McKee, M.C., Nanci, A. and Khan, S.R. 1995, Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi. J Bone Miner Res 10:1913-1929.

73. Atmani F. and Khan, S.R., 1995, Characterization of uronic-acid-rich inhibitor of calcium oxalate crystallization isolated from rat urine. Urological Research 23:95-101. 72. Woodard, J. C., Riser W.H., Morrone A.A. and Khan S.R., 1995, Articular chondrocalcinosis of the humeral head in greyhounds. Am. J. Vet. Res., 56: 473-480.

71. Hackett, R.L., Shevock, P.N. and Khan, S.R. 1995, Alterations in MDCK and LLC-PK1 cells exposed to oxalate and calcium oxalate monohydrate crystals. Scann Microsc 9: 587-596. 70. Khan, S.R. and P.A. Glenton, 1995, Deposition of calcium phosphate and calcium oxalate crystals in the kidneys. Journal of Urology, 153: 811-817.

69. Kok, D.J. and S. R. Khan, 1994, Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney International, 46: 847-854.

68. Hackett, R.L., Shevock, P.N. and S.R. Khan, 1994, Madin-Darby Canine Kidney Cells are injured by exposure to oxalate and calcium oxalate crystals. Urological Research, 22: 197-204.

67. Yang, B.C., S. Khan and J.L. Mehta 1994, Blockade of platelet-mediated relaxation in rat aortic rings exposed to xanthine-xanthine oxidase. American Journal of Physiology 35:H2212-2218.

66. Nichols, W.W., Nicolini, F.A., S. Khan, Saldeen, T.G.P. and J.L. Mehta 1993, Failure of prostacyclin analog iloprost to sustin coronary blood flow after recombinant tissue type plasminogen-induced thrombolysis in dogs. American Heart Journal 126:285-292.

65. Shevock, P.N., S.R. Khan and R.L. Hackett 1993, Urinary chemistry of the normal Sprague-Dawley rat. Urological Research 21:309-312.

64. Khan, S.R., P.O. Whalen and P.A. Glenton 1993, Heterogeneous nucleation of calcium oxalate crystals in the presence of membrane vesicles. J. Crystal Growth 134:211-218.

63. Khan, S.R. and R.L. Hackett 1993, Role of organic matrix in urinary stone formation: an ultrastructural study of crystal matrix interface of calcium oxalate monohydrate stones. Journal of Urology 150:239-245. 62. Khan, S.R., P.N. Shevock, and R.L. Hackett 1993, Magnesium oxide administration and prevention of calcium oxalate nephrolithiasis. Journal of Urology 149:412-416.

61. Nicolini, F.A., W.W. Nichols, T.G.P. Saldeen, S. Khan, J.L. Mehta 1992; Adjunctive therapy with low molecular weight heparin with rt-PA causes sustained reflow in canine coronary thrombosis.

40

American Heart Journal. 124:280-288.

60. Norman, S., S.R. Khan, P. Leelachaikul, D.R. Saloman 1992, Origin of cells in the coronary intima during acute vascular rejection of the transplanted human heart. Journal of Heart and Lung Transplantation, 11: 492-499.

59. Khan, S.R., P.N. Shevock, and R.L. Hackett 1992, Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis. Journal of Urology, 147: 226-230.

58. Gokhale, J.A. and S.R. Khan 1992, Structure of rat kidney following microwave accelerated fixation. Scanning Microscopy, 6:511-519.

57. Khan, S.R. and R.L. Hackett 1991, Retention of calcium oxalate crystals in renal tubules. Scanning Microscopy, 5:707-712.

56. Kumar, S., D. Sigmon, T. Miller, B. Carpenter, S. Khan, R. Malhotra, C. Sheid and M. Menon 1991, A new model of nephrolithiasis involving tubular dysfunction/injury. Journal of Urology, 146, 1384-1389.

55. Normann, S.J., D.R. Saloman, P. Leelachaikul, S.R. Khan, E. Staples, J.A. Alexander, W.R. Mayfield, L.A. Sadler, and S. Selman 1991, Acute vascular rejection of the coronary arteries in human heart transplantation: pathology and correlations with immunosuppression and cytomegalovirus (CMV) infection, Journal of Heart Transplantation, 10: 674-687.

54. Su, Chung-Jen, P.N. Shevock, S.R. Khan, and R.L. Hackett 1991, Effect of magnesium oxide administration on calcium oxalate urolithiasis. Journal of Urology, 145: 1092-1095.

53. Hackett, R.L., P.N. Shevock, P.N. and S.R. Khan 1990. Cell injury associated calcium oxalate crystalluria. Journal of Urology, 144, 1535-1538.

52. Khan, S.R. and E.J. Wilkinson 1990. Bladder stone in a human female: the case of an abnormally located intrauterine contraceptive device. Scanning Microscopy, 4: 395-398.

51. Klimberg, V.S., Souba W.W., Dolson, D.J., Salloum, R.M., Hautamaki, R.D., Plumley, D.A., Mendenhall, W.M., Bova, F.J., Khan, S.R., Hackett, R.L., Bland, K.I. and E.M. Copeland 1990: Prophylactic glutamine protects the intestinal mucosa from radiation injury. Cancer, 66: 62-68.

50. Khan, S.R., P.N. Shevock and R.L. Hackett 1990. Membrane associated crystallization of calcium oxalate in vitro. Calcified Tissue International, 46: 116-120.

49. Khan, S.R., P.N. Shevock, and R.L. Hackett 1989. Urinary Enzymes and Calcium Oxalate Urolithiasis. J. Urol. 142, 846-849.

48. Khan, S.R., P.N. Shevock and R.L. Hackett 1988. Presence of lipids in urinary stones: results of

41

preliminary studies. Calcified Tissue International 42, 91-96.

47. Benny G.L. and S.R. Khan 1988. Calcium oxalate crystals on the surface of some mucoralean fungi. Scanning Microscopy 2, 1199-1206.

46. Khan, S.R., P.N. Shevock and R.L. Hackett 1988. In vitro precipitation of calcium oxalate in the presence of whole matrix or lipid components of the urinary stones. J. Urol 139, 418-422.

45. Hackett, R.L. and S. R. Khan 1987. Presence of calcium oxalate crystals in the mammalian thyroid gland. Scanning Microscopy 2, 241-246.

44. Khan, S.R. and R.L. Hackett 1987. Crystal-matrix relationship in experimentally induced urinary calcium oxalate monohydrate crystals, an ultrastructural study. Calcified Tissue International, 41, 157-163.

43. Khan, S.R. and R.L. Hackett 1987. Role of scanning electron microscopy and x-ray microanalysis in the identification of urinary crystals. Scanning Microscopy, 1, 1405-1411.

42. Khan, S.R. and R.L. Hackett 1987. Urolithogenesis of mixed foreign body stones. J. Urol. 138, 1321-1328.

41. Baird R.E., and S.R. Khan, 1987. Spore ornamentation of north american Phellodon species. Mycologia 79, 334-337.

40. Khan, S.R., B. Finlayson, and R.L. Hackett, 1986. Morphology of urinary stone particles resulting from ESWL treatment. J. Urol., 136, 1367-1372.

39. Khan, S.R. and R.L. Hackett, 1986. Scanning electron microscopic histochemistry of colloidal iron stained calcium oxalate crystal associated material in human urinary stones and experimentally induced intrarenal deposits in rats. Scan. Electr. Microsc/II/ 761-765. 38. Baird, R.E., and S.R. Khan, 1986. The stipitate Hydnums (Thelephoraceae) of Florida. Brittonia 38:171-184.

37. Khan, S.R., and R.L. Hackett, 1986. Identification of urinary stone and sediment crystals by scanning electron microscopy and x-ray microanalysis. J. Urol. 135, 818-825.

36. Khan, S.R. and R.L. Hackett, 1985. Calcium oxalate urolithiasis in the rat: Is it a model for human urinary stone disease? A review of recent literature. Scan. Electr. Microsc./II/ 759-774.

35. Khan, S.R. and E.J. Wilkinson, 1985. Scanning electron microscopy as an analytical tool for the study of calcified intrauterine contraceptive devices. Scan. Electr. Microsc./III/ 1247-1251.

34. Khan, S.R. and E.J. Wilkinson, 1985. Scanning electron microscopy, x-ray diffraction, and

42

electron microprobe analysis of calcific deposits on intrauterine contraceptive devices. Human Pathology, 16, 732-738.

33. Khan, S.R., and R.L. Hackett, 1985. Developmental morphology of calcium oxalate foreign body stones in rats. Calcified Tissue International, 37, 165-173.

32. Khan, S.R., B. Finlayson, W.C. Thomas, Jr., R.L. Hackett, 1984. Relationship between experimentally induced crystalluria and relative supersaturation of various stone salts in rats. Urol. Res., 12, 271-273.

31. Khan, S.R., and R.L. Hackett, 1984. Microstructure of decalcified human calcium oxalate urinary stones. Scan. Electr. Micros./II, 935-941.

30. Khan, S.R., Charles A. Cockrell, B. Finlayson and R.L. Hakcett, 1984. Crystal retention by injured urothelium of the rat urinary bladder. J. Urol. 132, 153-157.

29. Khan, S.R., B. Finlayson and R.L. Hackett, 1984. Renal papillary changes in a patient with calcium oxalate lithiasis. Urology 23, 194-199.

28. Khan, S.R., B. Finlayson and R.L. Hackett, 1983. Agar embedded urinary stones: a technique useful for studying microscopic architecture. J. Urol. 130, 992-995.

27. Khan, S.R., B. Finlayson and R.L. Hackett, 1983. Experimental induction of crystalluria in rats using mini-osmotic pumps. Urol. Res. 11, 199-205.

26. Khan, S.R., B. Finlayson and R.L. Hackett, 1983. Stone matrix as proteins adsorbed on crystal surfaces: a microscopic study. Scan. Electr. Micros. /83/ I, 379-385.

25. Khan, S.R., B. Finlayson and R.L. Hackett, 1982. Structural changes in the rat renal papilla during oxalate nephrolithiasis. Am. J. Path. 107, 59-69.

24.Khan, S.R., B. Finlayson and R.L. Hackett, 1981. Light and scanning electron microscopic studies of oxamide urolithiasis in rats. Scan. Electr. Micros. /81/ III, 155-162.

23. Khan, S.R., and R.L. Hackett, 1980. The use of SEM in the study of oxalateinduced experimental nephrolithiasis. Scan. Electr. Micros. /80/ III, 379-386.

22. Khan, S.R., B. Finlayson and R.L. Hackett, 1979. Scanning electron microscopy of calcium oxalate crystal formation in experimental nephrolithiasis. Lab. Invest. 41, 504-510.

21.Khan, S.R., B. Finlayson and R.L. Hackett, 1979. Histological study of the early events in oxalate induced intranephronic calculosis. Invest. Urol. 17, 199-202.

20. Khan, S.R. and J.W. Kimbrough, 1982. A reevaluation of the Basidiomycetes based upon septal

43

and basidial structures. Mycotaxon. 15, 103-120.

19. Khan, S.R., J.W., Kimbrough and P. Webb, 1982. Fine structure of the dikaryotic mycelium of the Cronortium quercum fuciforme on Quercus rubra L. Mycologia 74, 809-819.

18. Khan, S.R., J.W. Kimbrough and K.J. KwonChung, 1981. Ultrastructure of Filobasidiella arachnophila. Can. J. Bot. 59, 893-897.

17. Khan, S.R., J.W. Kimbrough and C.W. Mims, 1981. Septal ultrastructure and taxonomy of Exobasidium. Can. J. Bot. 59, 2450-2457.

16. Khan, S.R. and J.W. Kimbrough, 1980. Ultrastructure and taxonomy of Eocronortium. Can. J. Bot. 58, 642-647.

15. Khan, S.R. and J.W. Kimbrough, 1979. Ultrastructure of septal pore apparatus in the lamellae of Nematolomma puiggarii. Can. J. Bot. 57, 2064-2070.

14. Khan, S.R. and J.W. Kimbrough, 1979. Septal ultrastructure in Tremellaceae. Can. J. Bot. 57, 55-80.

13.Khan, S.R. 1978. The golgi cisternae of Cunninghamella echinulata. Can. J. Bot. 56, 432-438.

12. Khan, S.R. 1977. Light and electron microscopic observations of sporangium formation in Albugo candida (Peronosporales: Oomycetes). Can. J. Bot. 55, 730-739.

11. Khan, S.R. 1976. Ultrastructure of the septal pore apparatus of Tremella. J. Gen. Microbiol. 97, 339-342.

10. Khan, S.R. 1976. Ultrastructural changes in maturing sporangia of Albugo candid. Ann. Bot. 40, 1285-1292.

9. Khan, S.R. and P.H.B. Talbot, 1976. Ultrastructure of septa in hyphae and basidia of Tulasnella. Mycologia 68, 1027-1036.

8. Khan, S.R. 1976. Paramural bodies of Albugo candida. Arch. Microbiol. 109, 271-276.

7.Khan, S.R. 1976. Electron microscopic observations of dividing somatic nuclei in Albugo. Can. J. Bot. 54, 168-172.

6.Khan, S.R. 1975. Wall structure and germination of spores in Cunninghamella echinulata. J. Gen. Microbiol. 90, 115-124.

5.Khan, S.R. and P.H.B. Talbot, 1975. Monosporous sporangiola in Mycotypha and

44

Cunninghamella. Trans. Br. Mycol. Soc. 65, 29-30.

4. Khan, S.R. and H.C. Aldrich, 1975. The haustoria of Termitaria snyderi Thax. J. Invert. Pathol. 25, 247-260.

3.Khan, S. R. and J.W. Kimbrough, 1974. Morphology and development of Termitaria snyderi. Thax. Mycologia 66, 446-462.

2.Khan, S.R. and J.W. Kimbrough, 1974. Taxonomic position of Termitaria and Mattirolella (Entomogenous Deuteromycets). Am. J. Bot. 61, 395-399.

1.Khan, S.R. and H.C. Aldrich, 1973. Conidiogenesis in Termitaria snyderi Thax. (Fungi Imperfecti). Can. J. Bot. 51, 2307-2314.

45

BOOKS, PROCEEDINGS & JOURNAL SPECIAL ISSUES:

6. Rodgers AL, Hibbert BE, Hess B, Khan SR, Preminger GM, Editors, Urolithiasis 2000 Vols 1 and 2, Proceedings of the 9th International Symposium on Urolithiasis, University of Cape Town, Rondebosch, Cape Town, South Africa, 2000.

5. Joseph W. Segura and Khan SR, Guest-Editors, J Endourology, Vol13 (9).

4. Khan, S.R., Guest Editor, Supplement 14, J Am Soc Nephrol 14:S323-S366, 1999.

3. Khan, S.R., Editor, Calcium Oxalate in Biological Systems, CRC Press, Boca Raton, 373 pages, 1995.

2. Khan, S.R., Guest Editor, Special Issue, Stones and Crystals, Scanning Microscopy Vol. 10 (2), Scanning Microscopy International, Chicago, pages 303-612, 1996.

1. Khan, S.R., Guest Editor, Proceedings of the Finlayson Colloquium, American Journal of Kidney Diseases 17 (4), pages 363-458, 1991.

BOOK CHAPTERS:

19. Khan SR, 2011, Renal Cellular Dysfunction/Damage and the Formation of Kidney Stones, In: Urinary Tract Stone Disease (NP Rao, GM Preminger, JP Kavanagh, eds.), Springer-Verlag London, 61-86

18. Khan SR, 2008, Macromolecules in Urinary Stone Formation and Urinary Inhibitors, In: Uriner Sistem Tas Hastaligi (AH Muslumanoglu, T Esen, A Tefekli, eds.), Nobel Tip Kitabevleri, Istanbul, Turkey, 27-56 (In Turkish)

17. Khan SR, Kok DJ, 2007, Modulators of crystallization of stone salts, In: Urinary Stone disease, The practical guide to medical and surgical management (ML Soller and MV Meng, eds.), Humana Press Inc, NJ, USA, 175-219.

16. Amos FA, Olszta MJ, Khan SR, Gower LB, 2006, Relevance of a polymer-induced liquid-precursor (PILP) mineralization process to normal and pathological biomineralization, In: Biomineralization Medical Aspects of Solubility (E and L-C Konigsberger, eds.) , John Wiley & Sons, Ltd, England, 125-217

15. Tiselius H-G, Borghi L, Brandle E, Buck C, Coe F, Hautmann R, Khan SR, Ryall RL, Schor N, Member, Biochemistry Committee, In: Stone Disease (J Segura , P Conort, S Khoury, C Pak, GM Preminger, D Tolley, eds.), First International Consultation on Stone Disease, held Paris 2001, Health Publications-2003, Paris, France, 31-122

14. Khan, S.R., 1997. Importance of calcium phosphates in the development of calcium

46

urolithiasis. In: Calcium Phosphates in Biological and Industrial Systems (Amjad, Z., ed.) Kluwer Academic Publishers, Boston, 252-275.

13. Khan, S.R., 1997. Calcium oxalate urolithiasis, rat. In: Urinary System, Monographs on Pathology of Laboratory Animals, Sponsored by International Life Sciences Institute (T.C. Jones, U. Mohr and R.T. Hunt, eds.), Springer-Verlag, New York, 4311-438.

12. Atmani, F., Gokhale, J.A., Khan, S.R., 1997. Urinary glycoprotein modulators of calcific nephrolithiasis. In: Urinary System, Monographs on Pathology of Laboratory Animals, Sponsored by International Life Sciences Institute (T.C. Jones, U. Mohr and R.T. Hunt, eds.), Springer-Verlag, New York,438-450.

11. Khan, S.R., 1997. Phosphate urolithiasis, rat. In: Urinary System, Monographs on Pathology of Laboratory Animals, Sponsored by International Life Sciences Institute (T.C. Jones, U. Mohr and R.T. Hunt, eds.), Springer-Verlag, New York,451-456.

10. Khan, S.R., 1995. Association between calcium phosphate and calcium oxalate crystals in the development of urinary stones. In: Mineral Scale Formation and Inhibition (Amjad, Z., ed.), Plenum Press, New York, 261-270.9. Adair, James H., Linhart R.V., Habeger F. and Khan, S.R., 1995. Mechanisms of calcium oxalate aggregation in the biophysical environment. In: Calcium Oxalate in Biological Systems (Khan, S.R., ed.), CRC Press, Boca Raton, 37-52.

8. Khan, S.R., 1995. Animal model of calcium oxalate nephrolithiasis. In: Calcium Oxalate in Biological Systems (Khan, S.R., ed.), CRC Press, Boca Raton, 343-359.

7. Khan, S.R., 1995. Lipid matrix of urinary calcium oxalate crystals and stones. In: Calcium Oxalate in Biological Systems (Khan, S.R., ed.), CRC Press, Boca Raton, 291-304.

6. Khan, S.R., Adair, J.H., Morrone, A.A. and G.P. Latorre, 1994, Calcium Phosphate Deposition in Rat Kidneys. In: Hydroxyapatite and Related Materials, (P.W. Brown and B. Constantz, eds.), CRC Press, Boca Raton, 325-329.

5. Khan, S.R., Hackett, R.L., 1994. Pathological crystallization of calcium oxalate and calcium phosphate. In: Hydroxyapatite and Related Materials, (P.W. Brown and B. Constantz, eds.), CRC Press, Boca Raton, 83-92.

4. Khan, S.R., 1992. Structure and development of calcific urinary stones. In: Calcification in biological systems, (E. Bonnuci, ed.), CRC Press, Boca Raton, 345-363.

3. Finlayson, B., Khan, S.R. and R.L. Hackett, 1990. Theoretical chemical models of urinary stones. In: Renal Tract Stones, Metabolic Basis and Clinical Practice, (J.E.A. Wickham and A.C. Buck, eds.), Churchill and Livingstone., New York, 133-147.

47

2. Khan, S.R., and J. Carroll Woodard, 1986. Calcium oxalate urolithiasis, rat. In: Urinary System, Monographs on Pathology of Laboratory Animals, Sponsored by International Life Sciences Institute (T.C. Jones, U. Mohr and R.T. Hunt, eds.), Springer-Verlag, New York, 355-361.

1.Woodard, J. Carroll, and S.R. Khan, 1986. Phosphate urolithiasis, rat. In: Urinary System, Monographs on Pathology of Laboratory Animals, Sponsored by International Life Sciences Institute (T.C. Jones, U. Mohr and R.T. Hunt, eds.), Springer-Verlag, New York, 364-369.

48

REVIEW ARTICLES:

23. Khan SR, 2012, Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urol Res. 40: 95-112.

22. Khan SR, 2011, Crystal/Cell interaction and nephrolithiasis. Arch Ital di Urolog, Androl 83: 1-5.

21. Khan SR, Canales B K., 2009, Genetic basis of renal cellular dysfunction and the formation of kidney stones. Urol Res 37: 169-180

20. Butterweck V, Khan SR, 2009, Herbal Medicines in the Management of Urolithiasis: Alternative or Complementary? Planta Medica

19. Talham DR, Backov R, Benitez IO, Sharbaugh DM, Whipps S, Khan SR., 2006, Role of lipids in urinary stones: studies of calcium oxalate precipitation at phospholipid langmuir monolayers. Langmuir 22: 2450-06.

18. Khan SR, 2006, Renal tubular damage/dysfunction: key to the formation of kidney stones. Urol Res 34: 86-91.

17. Khan SR, 2005, Hyperoxaluria-induced oxidative stress and antioxidants for renal protection.Urol Res. 33:349-57.

16. Khan SR, 2004, Role of renal epithelial cells in the initiation of calcium oxalate stones. Nephron Exp Nephrol 98:55-60

15. Khan SR, 2004, Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue culture studies. Clinical and Experimental Nephrology 8:75-88.

14. Khan SR and Kok DJ, 2004, Modulators of Urinary Stone Formation, Frontiers in Bioscience 9, 1450-1482

13. Khan SR, 2002, Stone research on the bench: where we are and where we are going. Text of the First Finlayson Memorial Lecture given at the annual ROCK Society meeting, Orlando, Florida; J Endourology 16 (6) 413-416.

12. Hess B, Ryall RL, Kavanagh JP, Khan SR, Kok DJ, Rogers AL, Tiselius HG, 2001, Methods for measuring crystallization in urolithiasis research: why, how and when? Eur Urol 40: 220-230.

11. Khan SR, Thamilselvan S, 2000, Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals. Mol Urol 4 (4): 305-311.

10. Khan SR, 1997, Animal models of kidney stone formation: an analysis. World J Urol. 15: 236-243.

49

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Khan+SR%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Whipps+S%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Sharbaugh+DM%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Benitez+IO%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Backov+R%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Talham+DR%22%5BAuthor%5D

9. Khan SR, 1997, Intercations between stone forming calcific crystals and macromolecules. Urologia Internationalis, 59: 59-71.

8. Khan SR, 1997, Tubular cell surface events during nephrolithiasis. Curr Opin in Urol, 7: 240-247.

7. Khan SR, 1996, Where do renal stone form and how? It J Min Electr Metabolism, 10:75-82.

6. Khan, S.R. 1995, Heterogeneous nucleation of calcium oxalate crystals in mammalian urine. Scann Microsc 9:597-616.

5. Khan, S.R.,1995, Mechanisms involved in calcium oxalate nephrolithiasis based on studies in an animal model. Italian J. Min Electr. Met. 9:3-9.

4. Khan, S.R., 1995, Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urological Research 23:71-79.

3. Khan, S.R. 1995, Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones. Scann Microsc 9:89-101

2. Khan, S.R., 1991, Pathogenesis of oxalate urolithiasis: Lessons from experimental studies with rats. American Journal of Kidney Diseases 17: 398-401.

1. Finlayson, B., S.R. Khan and R.L. Hackett, 1984. Mechanisms of urinary stone formation: an overview. Scan. Electr. Micros. /84/III, 1419-1425.

50

NON-REFEREED PUBLICATIONS (Proceedings):

70. Khan SR, 2011, Crystal-Cell Interaction and nephrolithiasis. Arch Ital Urol Androl 83: 1-5.

69. Gower LB, Amos FF, Khan SR., 2010, Mineralogical signatures of stone formation mechanisms. Urol Res., 38:281-92

68. Khan SR, 2010, Nephrocalcinosis in animal models with and without stones. Urol Res. 38: 429-438.

67. Khan SR, 2004, Animal models of calcium oxalate nephrolithiasis. In: Kidney Stones: Inside and Out (Eds. MDI Gohel & DWT Au), Proceedings of the 10th International Symposium on Urolithiasis, Hong Kong, May 25-28, 420-425.

66. Umekawa T, Byer KJ, Khan SR, 2004, NADPH oxidase as source of reactive oxygen species in oxalate and calcium oxalate induced injury of renal epithelial cells. In: Kidney Stones: Inside and Out (Eds. MDI Gohel & DWT Au), Proceedings of the 10th International Symposium on Urolithiasis, Hong Kong, May 25-28, published by The Hong Kong Polytechnic University, pp118-119.

65. Khan SR, Byer KJ, 2004, Possible protective role for citrate during crystal induced injury. In: Kidney Stones: Inside and Out (Eds. MDI Gohel & DWT Au), Proceedings of the 10th International Symposium on Urolithiasis, Hong Kong, May 25-28, 64-65.

64. Rabinovich Y, Esayanur M, Daosukho S, Byer K, El-Shall H, Gower L, Khan S, 2003, Direct measurement of the interaction force between calcium oxalate monohydrate and biological Cells. In: Urolithiasis, Proceedings of the 2nd Eurolithiasis Society Meeting, Istanbul June 11-14, 1-2

63. Diaz-Diurych CC, Raval AJ, Byer KJ, Khan SR, 2003, Involvement of calcium phosphate in idiopathic calcium oxalate nephrolithiasis. In: Urolithiasis, Proceedings of the 2nd Eurolithiasis Society Meeting, Istanbul June 11-14, 7-8.

62. Grewal JS, Tsai JY, Glenton PA, Byer KJ, Khan SR, 2003, Exposure to oxalate and calcium oxalate crystals induces the expression and production of an immunosuppressive lipocalcin, alpha-1-microglobulin in LLC-PK1 cells via intermediating reactive oxygen species. In: Urolithiasis, Proceedings of the 2nd Eurolithiasis Society Meeting, Istanbul June 11-14, 9

61. Umekawa T, Chegini N, Khan SR, 2003, Crystal induced expression of MCP-1 in renal epithelial cells in culture. In: Urolithiasis, Proceedings of the 2nd Eurolithiasis Society Meeting, Istanbul June 11-14, 13

60. El-Shall H, Jeon JH, Daosukho S, Rabinovich Y, Gower L, Khan S, 2003, Effect of citrate on nucleation and crystal growth of calcium oxalate monohydrate, In: Urolithiasis, Proceedings of the 2nd Eurolithiasis Society Meeting, Istanbul June 11-14, 69-70

51


http://www.ncbi.nlm.nih.gov/pubmed?term=%22Amos%20FF%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Gower%20LB%22%5BAuthor%5D

59. Umekawa T, Chegini N, Khan SR 2001, Calcium oxalate nephrolithiasis as an inflammatory disease, production of MCP-1 by renal epithelial cells exposed to xoalate and calcium oxalate crystals. In: Eurolithiasis, (DJ Kok, HC Romjin, PCMS Verhagen, CF Verkoelen, editors), Proceedings of the 9th European Symposium on Urolithiasis held September 13-15, 2001, Rotterdam, The Nerherlands, 23-26.

58. Thamilselvan S, Khan SR, Menon M, 2000, Antioxidant protecting against oxalate injury in renal epithelial cells. In: Abstract booklet of the Workshop on Oxalosis and Calcium Oxalate Stone Disease, held Nov 16-17, Columbia, Maryland, Presented by The NIDDK, NIH; page 49.

57. Khan SR, 2000, Animal model of hyperoxaluria, experimental induction. In: Abstract booklet of the Workshop on Oxalosis and Calcium Oxalate Stone Disease, held Nov 16-17, Columbia, Maryland, Presented by The NIDDK, NIH; pages 6-7.

56. Khan SR, Fasano JM, Backov R, Talham DR, 2000, Involvement of cellular membranes and their lipids in nucleation of stone forming crystals. In: Mineralization in Natural and Synthetic Biomaterials, edited by P. Li. P. Calvert, T. Kokubo, R. Levy, and C Scheid, Proceedings of Materials Research Society Symposium, held November 29-Dec 1, 1999, Boston, MA, Vol 599: 269-279.

55. Glenton PA, Khan SR, 2000, Renal brush border membrane lipids of normal and hyperoxaluric rats. In: Urolithiasis 2000, edited by Rodgers RL, Hibbert BE, Hess B, Khan SR, Preminger GM, Proceedings of the 9th International Symposium on Urolithiasis, held February 13-17, 2000, Cape Town, South Africa, University of cape Town, Rondebosch, Cape Town, South Africa, 287-288.

54. Glenton PA, Khan SR, 2000, Lipid comparison of five types of kidney stones. In: Urolithiasis 2000, edited by Rodgers RL, Hibbert BE, Hess B, Khan SR, Premionger GM, Proceedings of the 9th International Symposium on Urolithiasis, held February 13-17, 2000, Cape Town, South Africa, University of cape Town, Rondebosch, cape Town, South Africa, 285-286.

53. Thamilselvan S, Khan SR, 2000, Free radical scavengers, catalase and superoxide dismutase, provide protection from oxalate-associated injury to LLC-PK and MDCK cells. In: Urolithiasis 2000, edited by Rodgers RL, Hibbert BE, Hess B, Khan SR, Premionger GM, Proceedings of the 9th International Symposium on Urolithiasis, held February 13-17, 2000, Cape Town, South Africa, University of cape Town, Rondebosch, cape Town, South Africa, 229-231.

52. Khan SR, 2000, Crystal-cell interaction: the backbone of stone formation. In: Urolithiasis 2000, edited by Rodgers RL, Hibbert BE, Hess B, Khan SR, Premionger GM, Proceedings of the 9th International Symposium on Urolithiasis, held February 13-17, 2000, Cape Town, South Africa, University of cape Town, Rondebosch, cape Town, South Africa, 211-217.

51. Christmas KG, Gower LA, Adair JH, Khan SR, El-Shall H, 2000, Aggregation/dispersion chracteristics of calcium oxalate monohydrate crystals in the presence of protein and urinary ions. In: Urolithiasis 2000, edited by Rodgers RL, Hibbert BE, Hess B, Khan SR, Premionger GM, Proceedings of the 9th International Symposium on Urolithiasis, held February 13-17, 2000, Cape

52

Town, South Africa, University of cape Town, Rondebosch, cape Town, South Africa, 178-180.

50. Johnson-Tardieu J, Glenton PA, Moriyama M, Peck AB, Khan SR, 2000, Expression of inter-(-inhibitor related proteins in kidneys and urine of hyperoxaluric rats. In: Urolithiasis 2000, edited by Rodgers RL, Hibbert BE, Hess B, Khan SR, Premionger GM, Proceedings of the 9th International Symposium on Urolithiasis, held February 13-17, 2000, Cape Town, South Africa, University of cape Town, Rondebosch, cape Town, South Africa, 148-149.

49. Khan SR, McKee MD, 2000, Ultrastructural localization of matrix molecules in human kidney stones. In: Urolithiasis 2000, edited by Rodgers RL, Hibbert BE, Hess B, Khan SR, Premionger GM, Proceedings of the 9th International Symposium on Urolithiasis, held February 13-17, 2000, Cape Town, South Africa, University of cape Town, Rondebosch, cape Town, South Africa, 144-145.

48. Johnson-Tardieu J, Glenton PA, Moriyama M, Peck AB, Khan SR, 2000, Osteopontin expression in kidneys and urine of rats with hyperoxaluria and nephrolithiasis. In: Urolithiasis 2000, edited by Rodgers RL, Hibbert BE, Hess B, Khan SR, Premionger GM, Proceedings of the 9th International Symposium on Urolithiasis, held February 13-17, 2000, Cape Town, South Africa, University of cape Town, Rondebosch, cape Town, South Africa, 142-143.

47. Fasano JM, Khan SR, 2000, Intratubular crystallization in the presence of renal epithelial membrane vesicles. In: Urolithiasis 2000, edited by Rodgers RL, Hibbert BE, Hess B, Khan SR, Premionger GM, Proceedings of the 9th International Symposium on Urolithiasis, held February 13-17, 2000, Cape Town, South Africa, University of cape Town, Rondebosch, cape Town, South Africa, 52-54.

46.Atmani F, Khan SR, 1999, Urinary bikunin as a natural inhibitor of calcium oxalate crystallization. In: Kidney Stones, edited by Borghi L, Meschi T, Briganti A, Schianchi T, Novarini A, Proceedings of the 8th European Sympsoium on Urolithiasis, held in Parma, Italy; Editoriale Bios, page 257.

45. Khan SR, 1999, Oxalate and calcium oxalate crystals provoke renal epithelial cells: results of studies in rat models. In: Abstract booklet of the Workshop on New Horizons in the Pathogenesis, Treatment & Cure of Hyperoxaluria, Oxalosis & the Oxalate Stone Diseases, held Bethesda, Maryland, Presented by The NIDDK, NIH; page20.

44. Khan SR, 1999, Renal epithelial cells are provoked by exposure to both oxalate and calcium oxalate crystals: results of studies in a rat model of nephrolithiasis. Nephrol Dial Transplant 14: 2786.

43. Khan SR, Glenton PA, Byer KJ, 1999, Hyperoxaluric calcium oxalate stone forming rats. In: Abstract booklet of 2nd Finlayson Colloquium on urolithiasis, held Gainesville, Florida, sponsored by ROCK Society; page 45.

42. Atmani F, Khan SR, 1999, Role of urinary bikunin in the inhibition of calcium oxalate

53

crystallization. In: Abstract booklet of 2nd Finlayson Colloquium on urolithiasis, held Gainesville, Florida, sponsored by ROCK Society; page 38.

41. Byer, KJ, McCormack WT, Benson NA, Khan SR, 1999. Apoptosis in oxalate-associated injury of renal epithelial cells. In: Abstract booklet of 2nd Finlayson Colloquium on urolithiasis, held Gainesville, Florida, sponsored by ROCK Society; page 34.

40. Thamilselvan S, Khan SR, 1999, Cells of proximal and distal tubular origin respond differently to challenges of oxalate and calcium oxalate crystals. In: Abstract booklet of 2nd Finlayson Colloquium on urolithiasis, held Gainesville, Florida, sponsored by ROCK Society; page 32.

39. Fasano JM, Khan SR, 1999, Intratubular crystallization in the presence of renal tubular brush border membrane vesicles. In: Abstract booklet of 2nd Finlayson Colloquium on urolithiasis, held Gainesville, Florida, sponsored by ROCK Society; page 22.

38. Backov R, Khan S.R., Mingotaud C, Byer K, Nixon CM, Talham DR, 1999. Nucleation of calcium oxalate monohydrate at phosphilipid monolayers. In: Abstract booklet of 2nd Finlayson Colloquium on urolithiasis, held Gainesville, Florida, sponsored by ROCK Society; page 20.

37. Peck AB, Thamilselvan S, Cornelius JG, Khan S.R., Sidhu H, 1999, Direct correlation between hyperoxaluria/ oxalate stone disease and the absence of the GI-dwelling Bacterium Oxalobacter formigenes: treatment and prevention by gut recolonization and enzyme replacement therapy. In: Abstract booklet of 2nd Finlayson Colloquium on urolithiasis, held Gainesville, Florida, sponsored by ROCK Society; page 17.

36. Christmas KG, Khan SR, Gower LA, Adair JA, El-Shall H, 1999, Interaction of Macromolecules with Calcium Oxalate Monohydrate Crystals in the Presence of Urinary Ions, presented at the Federation of American Societies for Experimental Biology Research Conference: Calcium Oxalate in Biological Systems, Denver, Colorado, August, 1999

35. McKee MD, Nanci A, Khan S.R., 1997, Ultrastructural localization of Tamm-Horsfall protein in human calcium oxalate kidney stones. In: Renal Stone Disease, Crystallization process, Pathophysiology, Metabolic disorders and Prevention , (P Jungers and M Daudon, eds.) Proc. 7th European Symposium on Urolithiasis, Paris, France, 124-125.

34. Atmani F, Opalko FJ, Khan S.R., 1997, Cellular membranes present in the urine promote crystallization of calcium oxalate. In: Renal Stone Disease, Crystallization process, Pathophysiology, Metabolic disorders and Prevention , (P Jungers and M Daudon, eds.) Proc. 7th European Symposium on Urolithiasis, Paris, France, 143-144.

32. Thamilselvan S, Hackett R.L., Khan S.R., 1997, Oxalate induced oxidative cellular injury of renal epithelial cells. In: Renal Stone Disease, Crystallization process, Pathophysiology, Metabolic disorders and Prevention , (P Jungers and M Daudon, eds.) Proc. 7th European Symposium on Urolithiasis, Paris, France, 141-142.

54

31. Khan, S.R., 1996, Association between calcium phosphate and calcium oxalate crystals in the development of urinary stones. In: Mineral Scale Formation and Inhibition, (Z. Amjad, ed.), Plenum Press, New York, 261-270.

30. Achilles, W., Kroning, M., Schaper, A., and S.R. Khan, 1995. Specific nucleation of spherulitic calcium phosphate and calcium oxalate crystals in a gel matrix. In: Urolithiasis: Consensus and Controversies, (P.N. Rao, J.P. Kavanagh and H.-J. Tiselius, eds.) Proc. 5th European Urolithiasis Symposium, Manchester, England, 275-277.

29. Khan, S.R. and F.J. Opalko, 1995. Constant composition crystallization system. In: Urolithiasis: Consensus and Controversies, (P.N. Rao, J.P. Kavanagh and H.-J. Tiselius, eds.) Proc. 5th European Urolithiasis Symposium, Manchester, England, 83-87.

28. Achilles W., and S.R. Khan, 1995. The matrix for in vivo crystal initiation. In: Urolithiasis: Consensus and Controversies, (P.N. Rao, J.P. Kavanagh and H.-J. Tiselius, eds.) Proc. 5th European Urolithiasis Symposium, Manchester, England, 5-11.

27. Khan, S.R., R.L. Hackett, 1995. Membranous cellular degradation products as nucleators. In: Urolithiasis: Consensus and Controversies, (P.N. Rao, J.P. Kavanagh and H.-J. Tiselius, eds.) Proc. 5th European Urolithiasis Symposium, Manchester, England, 13-21.

26. Sindhu, S., K.V. Kurien, K.V., G.N. Subhanna, P. Koshy, S.R. Khan, and Y.M. Fazil Marickar, 1994. Purity of crystals grown in vitro in the presence of dopants. In: Urolithiasis 2, (R. Ryall, R. Bais, V.R. Marshall, L.H. Smith and V.R. Walker, eds.,), Plenum Press, New York, 236

25. Cohen, M.C., R. Lobinske and S.R. Khan, 1994. Do bacterial membranes contribute to calcium oxalate (CaOx) crystal deposition. In: Urolithiasis 2, (R. Ryall, R. Bais, V.R. Marshall, L.H. Smith and V.R. Walker, eds.,), Plenum Press, New York, 347-349.

24. Adair, J.H., T. Nagira, S.R. Khan, C.M. Brown and W.C. Thomas, 1994. Heterogeneous deposition of calcium phosphates at the silicon (hydrous) xide-water interface. In: Urolithiasis 2, (R. Ryall, R. Bais, V.R. Marshall, L.H. Smith and V.R. Walker, eds.,), Plenum Press, New York, 181-183.

23. Hackett, R.L., P.N. Shevock and S.R. Khan, 1994. Inhibition of calcium oxalate monohydrate seed crystal growth is decreased in renal injury. In: Urolithiasis 2, (R. Ryall, R. Bais, V.R. Marshall, L.H. Smith and V.R. Walker, eds.,), Plenum Press, New York,343-345.

22. Hackett, R.L., P.N. Shevock and S.R. Khan, 1994. Calcium oxalate crystals and ions are injurious to renal epithelial cells. In: Urolithiasis 2, (R. Ryall, R. Bais, V.R. Marshall, L.H. Smith and V.R. Walker, eds.,), Plenum Press, New York,325-327.

21. Khan, S.R., C-J Su, P.N. Shevock, and R. L. Hackett, 1994. Beneficial effect of magnesium oxide

55

administration on calcium oxalate urolithiasis. In: Urolithiasis 2, (R. Ryall, R. Bais, V.R. Marshall, L.H. Smith and V.R. Walker, eds.,), Plenum Press, New York, 657.

20. Khan, S.R., P.N. Shevock, J.D. Sallis and R. L. Hackett, 1994. Phosphocitrate as an inhibitor of calcium oxalate crystallization in vivo. In: Urolithiasis 2, (R. Ryall, R. Bais, V.R. Marshall, L.H. Smith and V.R. Walker, eds.,), Plenum Press, New York, 229.

19. Khan, S.R. and R. L. Hackett, 1994. Renal epithelial injury: a risk factor in urolithiasis. In: Urolithiasis 2, (R. Ryall, R. Bais, V.R. Marshall, L.H. Smith and V.R. Walker, eds.,), Plenum Press, New York, 29-33. 18. Khan, S.R. and R. L. Hackett, 1994. Role of organic matrix in the formation and growth of calcium oxalate urinary stones. In: Urolithiasis 2, (R. Ryall, R. Bais, V.R. Marshall, L.H. Smith and V.R. Walker, eds.,), Plenum Press, New York, 321-323.

17. Khan, S.R. and R.L. Hackett, 1993, Backscattered electron imaging of urinary stone matrix. Scanning 15, Supplement III: 84-85.

16. Khan, S.R. and R.L. Hackett, 1993, Hyeproxaluria, enzymuria and nephrolithiasis. Contributions to Nephrology; Kidney, Proteins and Drugs: An Update, (C. Bianchi, V. Bocci, F.A. Carone, R. Rabkin, eds.) Karger, Basel, Switzerland, 101:190-193.

15. Khan S.R. and L.H. Smith, 1991. Introduction to Proceedings of the Finlayson Colloquium. J. Kid. Diseases 17, 363.

14. Khan S.R., 1990. Calcification of intrauterine contraceptive devices (IUDs), In: Proceedings of the XIIth International Congress for Electron Microscopy ,(G.W. Bailey,ed.), San Fransisco Press, Inc, San Fransisco,

13. Khan S.R. and Hackett R.L., 1989. Membrane-induced calcium oxalate crystal nucleation. In: Urolithiasis, (V.R. Walker, R.A.L. Sutton, E.C. Bert Cameron, C.L. Pak and W.G. Robertson, eds.) Plenum Publishing Corporation, New York, 121-123.

12. Khan S.R. and Hackett R.L., 1989. Renal proximal tubular injury and crystallization of calcium oxalate in rat urine. In: Urolithiasis, (V.R. Walker, R.A.L. Sutton, E.C. Bert Cameron, C.L. Pak and W.G. Robertson, eds.) Plenum Publishing Corporation, New York, 117-119.

11. Khan S.R., Shevock P.N. and Hackett R.L., 1989. Lipids of calcium oxalate urinary stones. In: Urolithiasis, (V.R. Walker, R.A.L. Sutton, E.C. Bert Cameron, C.L. Pak and W.G. Robertson, eds.) Plenum Publishing Corporation, New York, 125-127.

10. Finlayson B., Khan S.R. and Hackett R.L., 1989. Gentamicin accelerates calcium-oxalate-monohydrate (COM) nucleation. In: Urolithiasis, (V.R. Walker, R.A.L. Sutton, E.C. Bert Cameron, C.L. Pak and W.G. Robertson, eds.) Plenum Publishing Corporation, New York, 59-60.

56

9. Ackermann, D., P. Brown and S.R. Khan, 1989. Preparation and application of calcium oxalate dihydrate crystal seeds. Urol. Res. 17:147-148.

8. Khan, S.R. 1988. Urinary Stone Analysis, In: Proceedings of the 46th Annual Meeting of the Electron Microscopy Society of America, (G.W. Bailey,ed.), San Fransisco Press, Inc, San Fransisco, 86-87.

7. Khan, S.R., B. Finlayson and R.L. Hackett, 1985. A microscopic study of the matrix of some calcium oxalate renal stones, In: Urolithiasis and Related Clinical Research, Proc. Vth Intl. Symp. Urol. Res. (P.O. Schwille, L.H. Smith, W.G. Robertson and W. Vahlensieck, eds.), Plenum Publishing Corporation, New York, 923-925.

6. Khan, S.R., B. Finlayson and R.L. Hackett, 1985. Microstructure of calcium oxalate foreign body stones produced in rat bladder, In: Urolithiasis and Related Clinical Research, Proc. Vth. Intl. Symp. Urol. Res. (P.O. Schwille, L.H. Smith, W.G. Robertson and W. Vahlensieck, eds.), Plenum Publishing Corporation New York, 937-940.

5. Newkirk, J.W. and S.R. Khan, 1984. The stability of calcium oxalate during electron irradiation in an AEM. Proc. 42nd Ann. Meet. Elect. Mirosc. Soc. Am., San Fransisco Press, San Fransisco, California, 270-171.

4. Khan, S.R., R.L. Hackett, W.C. Thomas, Jr. and B. Finlayson, 1984. Kinetics of calcium oxalate encrustation on plastic foreign bodies in rat urinary bladders, In: Urinary Calculus, Proc. IInd Intl. Urin. Stn. Conf., Singapore, (R.L. Ryall, J.G. Brockis, V.R. Marshall and B. Finlayson, eds.), Churchill Livingstone, N.Y., 363-371.

3.Khan, S.R., B. Finlayson and R.L. Hackett, 1981. Rat renal papillary structure in oxalateinduced microlithiasis, a scanning electron microscopic study, In: Urolithiasis: clinical and basic research, Proc. IVth Intl. Symp. Urol. Res. (L.H. Smith, W.G. Robertson and B. Finlayson, eds.), Plenum Publishing Corporation, New York, 517-521.

2. Khan, S.R., B. Finlayson and R.L. Hackett, 1981. The ultrastructure of rat renal tubules in experimental calcium oxalate nephrolithiasis, In: Urolithiasis: clinical and basic research. Proc. IVth Intl. Symp. Urol. Res. (L.H. Smith, W.G. Robertson and B. Finlayson, eds.), Plenum Publishing Corporation, New York, 523-525.

1. Buscemi, P.J., E.P. Golberg, S.R. Khan, R.L. Hackett and B. Finlayson, 1981. Observations on whewellite stone matrix, In: Urinary Calculus, Proc. Intl. Ur. Stn. Conf. (J.G. Brockis and B. Finlayson, eds.), P.S.G. Publishing Company Inc., Littleton, Mass., 275-284.

57

MISCELLANEOUS PUBLICATIONS (Abstracts, Letters): 145. Joshi S, Saylor B, Wang W, Peck A, Khan S, 2012, Genome wide analysis of differentially expressed genes in the kidneys of a rat nephrolithiasis model. J Urol 187: e856-e857

144. Khan S, Glenton P, 2012, Increased urinary excretion of kidney injury molecule (KIM), osteopontin (OPN), hydrogen peroxide (HP), and monocyte chemoattractant protein-1 (MCP-1), a good indicator of renal calcioum oxalate (CaOx) crystal deposition and perhaps of stone formation. J Urol 187: e853 143. Khan, A, Gilani AH, Khan SR, 2011, Expression of Matrix Gla Protein in MDCK cells exposed to oxalate, calcium oxalate monohydrate and hydroxyapatite crystals. European Urology Supplement 10 (#7): 466

142. Khan S, Khan A, Glenton P, Zuo J, 2011, Effect of apocynin on expression of kidney injury molecule-1 and calcium oxalate crystal deposition in hyperoxaluric rats. J Urol 185: e820

141. Khan S, Canales B, Monga M, 2011, Formation and growth of Randall’s plaques: an ultrastructural study of renal papillae from idiopathic stone formers . J Urol 185: e861

140. Canales B, Khan S, 2010, Development of interstitial calcium phosphate deposits in sodium phosphate co-transporter (npt2a) null mice. J Urol 185: e821

139. Saeed Khan, Benjamin Canales, 2010, Of mice and men: male gender, hyperoxaluria and hypercalciuria promote calcium oxalate stone formation in mice, J Urol 183: e763

138. Yan Liu, Lan Mo, David Goldfarb, Andrew Evan, Fengxia Liang, Saeed Khan, John Lieske, Xue-Ru Wu, 2010, Ultra-structural study of renal papillary calcinosis in tamm-horsfall protein knockout mice: relation to randall's plaques in humans, J Urol. 183: e764-e765

137. Benjamin Canales, Saeed Khan, 2010, Resolution of renal papillary injury and Randall's plaque in a rodent model J Urol 183: e765-e766

136. Khan SR, 2010. Randall's plaque as metastatic calcification in renal papillary interstitium, evidence from an experimental animal model. Eur Urol Suppl 9(2):166

135. Khan SR and Canales B, 2009, Randal's plaque and papillary injury. Urology 74: S24

134. Canales B, Meguid M, Glenton P, Ryes L, Reinhard M and Khan S, 2009, Renal Histological Changes after Roux-En-Y gastric bypass surgery in a diet induced obese rat model. Urology 74: S74

133. Khan S and Canales B, 2009, Renal papillary injury and Randall's plaque. Arch It Urol Androl 81: 122-123

58

132. Canales BK, Ryes L, Glenton PA, Chow M, Chen S, Khan SR, 2009, Differential renal tissue protein profiling in a mouse model of hypercalciuria: effect of high oxalate diet. J Urol 181: 724-725

131. Canales BK, Khan SR, Glenton PA, Reyes L, Reinhard MK, Goncalves CG, Meguid MM, 2009, renal histological changes after RYGB in a diet induced obese rat model. J Urol 181: 721

130. Pattaraporn V, Butterweck V, Khan SR, 2009, Hyperoxaluria is reduced and crystal deposition prevented by an herbal extract in hyperoxaluric rats. J Urol. 181: 523

129. Khaskhali M H, Khan SR, 2008, Effect of calcium on calcium oxalate crystal induced renal epithelial injury. J. Urology 179:508

128. Escobar C, Byer KJ, Khan SR, 2007, Biocrystals are less injurious to renal tubular epithelial cells than the inorganic crystals. European Urology Meetings 2 (1):67

127. Khan SR, 2007, Hypercalciuria and formation of kidney stones. European Urology Meetings 2 (1): 70

126. Venachayangkul P, Byer K, Butterweck V, Khan SR, 2007, Ammi visnaga L. (Khella) extract prevents cell damage caused by oxalate and calcium oxalate crystals. European Urology Meetings 2 (1):35

125. Daisukho S, Svoronos S, El-Shall H, Rabinovich Y, Byer K, Venachayangkul P, Butterweck V, Khan SR, 2007, Effect of Khella (Ammi visnaga) extract on kidney stone formation. European Urology Meetings 2 (1): 97

124. Lawrence L Yeung LL, Johannes W Vieweg JW, Khan SR, Newman RC, Dahm P, 2006, A tribute to the life and accomplishments of Birdwell Fnlayson. J Urol 177: 354

123. Khan SR, Priola KB, Glenton PA, 2006, Calcium oxalate/calcium phosphate association in kidney stones. J Urol 177:309

122. Khan SR, 2007, Randall's plaque and renal injury. Kidney Int.71:83

121. Khan SR, Glenton PA, Byer KJ, 2007, Dietary oxalate and calcium oxalate nephrolithiasis- results of an experimental study. Abstracts, Bone, Stone and Kidney, WCN 07 Satellite Synposium, Rio de Janeiro, Brazil, April 26-28

120. Khan SR, 2006, Re: Dietary oxalate loads and renal oxalate handling. R. P. Holmes, W. T. Ambrosius and D. G. Assimos, J Urol 175:1576.

119. Umekawa T, Uemura H, Khan SR, 2006, Reactive oxygen species as second messenger for expression of MCP-1 in NRK52E cell exposed to calcium oxalate monohydrate crystal. JOURNAL OF

59

http://apps.isiknowledge.com:80/WoS/CIW.cgi?SID=D11f7bO9iI71PBfpELl&Func=Abstract&doc=2/4


UROLOGY 175 (4): 336-336

118. Khan SR, Byer KJ, Glenton PA, 2006, Rat model of hydroxy-L-proline induced calcium oxalate nephrolithiasis. JOURNAL OF UROLOGY 175 (4): 497-497

117. Khan SR.Re, 2006, Dietary oxalate loads and renal oxalate handling R. P. Holmes, WT Ambrosius and DG Assimos. JOURNAL OF UROLOGY 175 (4): 1576-1576

116. Khan SR, Umekawa T, Iguchi M, Uemura H, 2005, Oxalate ions induce up-regulation of osteopontin and MCP-1 by renal epithelial cells and interstitial fibroblasts. J Leukocyte Biol 32: 28 Suppl.

115. Khan SR, Habibzadegah-Tari P, 2004, Expression of MCP-1 in HK-2 cells: induction by oxalate and calcium oxalate crystals and involvement of reactive species. J Am Soc Nephrol 15: 474A

114. Khan S, 2004, Apoptotic changes in renal epithelial cells exposed to oxalate and calcium oxalate crystals: possible contribution to the development of kidney stones. BJU International 94 (Suppl 2): 98

113. Khan SR, Byer KJ, 2004, Reactive oxygen species as mediators of kidney stone formation, FASEB JOURNAL 18 (5): A942-A942 Suppl.

112. Khan, SR and Byer KJ, 2004, Citrate provide protection against oxalate and calcium oxalate crystal induced oxidative damage to renal epithelium. J Urol 171: 296.

111. Delvecchio FC, Brizuela RM, Byer KJ, Springhart WP, Zhong P, Khan SR, Preminger GM, 2004, Citrate and vitamin E blunt the SWL-induced free radical surge in an in vitro MDCK cell culture model. J Urol 171:295.

110. Umekawa T, Byer KJ, Khan SR, 2004, NADPH oxidase as source of reactive oxygen species in oxalate and calcium oxalate induced injury of renal epithelial cells. Urol Res 32:145

109. Khan SR, Byer KJ, 2004, Possible protective role for citrate during crystal induced injury. Urol Res. 32:139 108. Talham DR, Benitez IO, Backov R, Khan SR, 2003, Growth of calcium oxalate monohydrate at phospholipid monolayers, Abstracts of papers of the American Chemical Society, 225: 277-inor part 2.

107. Diaz-Diurych CC, Raval AJ, Byer KJ, Khan SR, 2003, Invlvement of calcium phosphate in idiopathic calcium oxalate nephrolithiasis, Urol Res. 31:75

106. Grewal JS, Tsai JY, Glenton PA, Byer KJ, Khan SR, 2003, Exposure to oxalate and calcium oxalate crystals induces the expression and production of an immunosuppressive lipocalcin, alpha-

60

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Khan+SR%22%5BAuthor%5D



1-microglobulin in LLC-PK1 cells via intermediating reactive oxygen species. Urol Res. 31: 76

105. Umekawa T, Chegini N, Khan SR, 2003, Crystal induced expression of MCP-1 in renal epithelial cells in culture. Urol Res. 31: 77

104. El-Shall H, Jeon JH, Daosukho S, Rabinovich Y, Gower L, Khan S, 2003, Effect of citrate on nucleation and crystal growth of calcium oxalate monohydrate. Urol Res. 31: 88

103. Rabinovich Y, Esayanur M, Daosukho S, Byer K, El-Shall H, Gower L, Khan S, 2003, Direct measurement of the interaction force between calcium oxalate monohydrate and biological Cells. Urol Res. 31: 75

102. Umekawa U, Kurita T, Khan SR, 2003, Angiotensin II receptor blockade prevents calcification in ethylene glycol treated rats. J Urol 169: 330

101. Khan SR, Glenton PA, Backov R, Talham DR, 2002, Lipids in urine, crystals and stones: do they have a role in he formation of kidney stones? BJU International 90 (Suppl 2), 257

100. IIDA s, Chikama S, Ishimatsu M, Inoue M, Matsuoka K, Noda S, Khan SR, 2002, Role of heparin sulfate on cultured epithelial cells during oxalate exposure. BJU International 90 (Suppl 2), 255

99. Grewal JS, Tsai JY, Ghlenton PA, Byer KJ, Khan SR, 2002, Oxalate toxicity induces an immunosuppressive lipocalin, 1-miroglobulin in LLC-PK eclls via intermediating reactive oxygen species. J Am Soc Nephrol 13: 492A

98. Hatanaka Y, Umekawa T, Kurita T, Khan SR, 2002, Angiotensin II Type 1 receptor blockade prevents calcification in ethylene glycol treated rat kidney-relation to kidney inflammation. J Am Soc Nephrol 13: 576A

97. Khan SR, Glenton PA, Backov R, Talham D, 2002, Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones. J Am Soc Nephrol 13:388A

96. Thamilselvan S, Hiong X, Khan S, Menon M, 2002, Effect of vitamin E on oxalate induced injury to renal epithelial cells. J Am Soc Nephrol 13:388A

95. Umekawa T, Kurita T, Khan SR, 2002, Calcium oxalate monohydrate and brushite crystals and oxalate ions stimulate MCP-1 production in NRK 52 E cells. J Urology 167: 258

94. Khan SR 2002, Inflammation associated with calcium oxalate crystal deposition in the kidneys: Secretion of chemokines by tubular peithelial cells on exposure to oxalate and calcium oxalate crystals. Abstracts of 6th European Workshop on Hyperoxaluria, held April 5-6, Hannover, Germany. Page 25. 93. Umekawa T, Chegini N, Khan SR 2001, Calcium oxalate nephrolithiasis as an inflammatory

61

disease, production of MCP-1 by renal epithelial cells exposed to xoalate and calcium oxalate crystals. Arch Ital Urol Androlog 73: 61-62.

92. Thamilselvan S, Khan S, Menon M 2001, Effect of vitamin E on cellular antioxidant enzymes after oxalate exposure to renal culture cells. J Am Soc Nephrol 12: 806A.

91. Umekawa T, Chegini N, Khan SR 2001, Renal epithelial cells produce MCP-1 in culture and its expression and production is increased by exposure to oxalate ions and calcium oxalate crystals. J Am Soc Nephrol 12: 759A.

90. Khan SR, Reddy RK, Byer KJ, Glenton PA, 2001, Organic matrix of kidney sones: its location, composition, and role in stone formation. 1st International Consultation on Stone Disease, Organized by Am Urol Assoc, Con Am Urol, Eur Assoc Urol, Urol Asssc Asia, Soc Endourol, WHO, Intl Consul Urol Dis, Intl Soc Urol, Palais des Congress, Paris, France, July 3-4.

89. Khan SR, Backov R, Talham D, 2001, Nucleation of Calcium oxalate at Langmuir monolayers. Abstracts, Chemcon 2000, Proceedings of the 1st international and 11th National Chemistry Confetrence, April 10-14, 2001, Peshawar University, Peshawar, Pakistan. 88. Khan SR, Glenton PA, 2001, Does hyperoxaluria induce cytoprotective response by the kidneys. J Urol, 165(Supplement): 247.

87. Khan SR, Thamilselvan S, 2000, Effect of antioxidants on oxalate induced lipid peroxidation in renal epithelial cells. J Am Soc Nephrol 11: 609A.

86. Khan SR, Fasano Julie M, 2000, Membrane-mediated crystallization of calcium oxalate in renal tubules. J Am Soc Nephrol 11: 565A.

85. Khan SR, Thamilselvan S, 2000, Antioxidants; vitamin E, Catalase and superoxide dismutase protect LLC-PK1 cells from oxalate-induced injury. The 3rd International Symposium on anti-oxidants and free radicals in health and disease. Vancouver, July 22-25.

84. Maslamani SA, Khan SR, Glenton PA, 2000, Effect of processing on macromolecular composition of the urine. J Urol 163:231.

83. Thamilselvam S, Khan SR, 2000, Protective effect of vitamin E against oxalate induced free radical injury to LLC-PK1 cells. J Urol 163:207.

82. Khan SR, Fasano JM, Backov R, Talham DR, 1999, Involvement of cellular membranes and their lipids in nucleation of stone forming crystals. Abstracts, Materials Research Society, Fall Meeting, Boston, Nov 29-Dec3. Page 547.

81. Atmani F, Khan SR, 1999, Urinary bikunin as a natural inhibitor of calcium oxalate crystallization. Arch Ital Urologia Andrologia 121:73.

62

80. Khan SR, 1999, Inhibitors and Promoters of Stone Growth, Abstracts of the 1st Istanbul Symposium on Urolithiasis, Istanbul, Turkey, page 16.

79. Khan SR, 1999, calcium oxalate crystals are injurious to renal epithelial cells: results of studies in rat model of hyperoxaluria. Abstracts of the 1st Istanbul Symposium on Urolithiasis, Istanbul, Turkey, page 18.

78. Moriyama MT, Johnson-Tardieu J, Glenton PA, Khan SR, 1999. Expression of inter-alpha-inhibitor related proteins in kidneys and urine of hyperoxaluric rats. J Urol 161:249.

77. Thamilselvan S, Byer K, Khan SR, 1999, Antioxidant scavengers protect LLC-PK1 and MDCK cells from oxalate and calcium oxalate monohydrate crystal- associated cellular injury. J Urol 161:248.

76. Khan SR 1998, Oxalate and calcium oxalate crystals provoke renal epithelial cells: results of studies in rat model; In: Proceedings of Workshop on New Horizons in the Pathogenesis, Treatment & Cure of Hyperoxaluria, Oxalosis & Oxalate Stone Diseases; Sponsored by The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH; held December 8-9, 1998, Bethesda, Maryland, Page 20.

75. Peck Ammon B, Thamilselvan S, Hesse A, Khan S, Sidhu H 1998. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the GI-dwelling bacterium, Oxalobacter formigines: treatment and prevention by the gut recolonization and enzyme-replacement therapy; In: Proceedings of Workshop on New Horizons in the Pathogenesis, Treatment & Cure of Hyperoxaluria, Oxalosis & Oxalate Stone Diseases; Sponsored by The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH; held December 8-9, 1998, Bethesda, Maryland, Page 38.

74. Iida S, Peck AB, Byer K, Johnson-Tardieu J, Glenton PA and Khan SR 1998. Expression of bikunin mRNA in the renal epithelial cells. J Urol 159: 172.

73. Fasano JM, Khan SR, 1998. Effect of renal tubular brush border membrane on crystallization in renal tubules. J Urol 159: 172.

72. Johnson-Tardieu J, Glenton P, Byer K, Peck AB and Khan, S.R., 1997. Changes in urinary protein profiles in an animal model of hyperoxaluria and calcium oxalate nephrolithiasis. J Am Soc Nephrol 8: 563A.

71. Iida S, Johnson-Tardieu J, Glenton P, Byer K, Peck AB and Khan, S.R., 1997. Molecular detection of bikunin in normal and oxalte exposed kidneys and renal epithelial cells. J Am Soc Nephrol 8: 563A.

70. Atmani F., Opalko F.J. and Khan, S.R., 1997. Membranous substances present in the whole urine promote calcium oxalate crystallization. J Urol 157: 408.

63

69. Sivagnanan Thamilselvan, Hackett R.L. and Khan S.R., 1997. LLC-PK1 cells are more susceptible than MDCK cells to oxalate induced oxidative cellular injury. J Urol 157: 19.

68. Atmani F., and Khan, S.R., 1996. Inter-(-inhibitor, another serum protein with potential involvement in calcium oxalate nephrolithiasis. J Am Soc Nephrol 7: 1798.

67. Thamilselvan S, Hackett R.L. and Khan S.R., 1996. Oxalate toxicity in the kidney and in LLC-PK1 and MDCK cells is mediated by lipid peroxidation. J Am Soc Nephrol 7: 1808.

66. Atmani F., McKee M.D. and Khan, S.R., 1996. Osteopontin in organic matrix of calcium oxalate crystals and stones. J Urol 155: 642A.

65. Thamilselvan S, Hackett R.L. and Khan S.R., 1996. Lipid peroxidation in experimental nephrolithiasis. J Urol 155: 642A.

64. Gokhale JA, Khan S.R., 1996. In vivo and in vitro analysis of Tamm-Horsfall protein (THP) from normal rats and rats with induced nephrolithiasis. J Urol 155: 640A.

63. Atmani F., Khan S.R., 1995. Association of urinary macromolecules with calcium phosphate crystals induced in human urine. J Am Soc Nephrol 6: 942.62. Atmani F., Mizon, J., Enghild, J.J. and Khan, S.R., 1995, Uronic acid rich protein and bikunin: a comparative study. J Bone Min Res 10: S488.

61. Khan, S.R., Glenton P.A., 1995. Urinary excretion of lipids by kidney stone patients. Proceedings of the VIth European Symposium on Urolithiasis,June 8-10,Stockholm,Sweden. page 49.

60. Gokhale J.A., P.A. Glenton and S.R. Khan, 1995. Study of Tamm-Horsfall Protein (THP) from normal and nephrolithic rats by in vitro crystal sedimentation assays. Proceedings of the VIth European Symposium on Urolithiasis, June 8-10, Stockholm, Sweden. page 50.

59. Atmani, F., Mizon J., Khan, S.R., 1995. Comparision of calcium oxalate inhibitory activity of uronic acid rich protein, inter-(-trypsin inhibitor, and urinary bikunin. Proceedings of the VIth European Symposium on Urolithiasis, June 8-10, Stockholm, Sweden. page 53.

58. Atmani, F., Opalko, FJ, Khan, S.R., 1995. Incorporation of osteopontin into calcium oxalate crystals induced in human and rat urine in vitro. Proceedings of the VIth European Symposium on Urolithiasis, June 8-10, Stockholm, Sweden. page 54.

57. Glenton, P., and Khan, S.R., 1994, Quantifying lipids of the urinary stones. Separations 9:8.

56. McKee, M.D., Nanci, A. and Khan, S.R. 1994. Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of urinary calculi. J. Bone Mineral Res., 9(suppl 1):S379.

64

55. S.R. Khan and P.A. Glenton, 1994. Lipid profile of calcific stone formers urine. Abstracts of 27th Ann Meeting of Am Soc Nephrol J Am Soc Nephr, p866.

54. Gokhale J.A. P.A. Glenton and S.R. Khan, 1994. Localization of Tamm Horsfall protein and osteopontin in rat nephrolithiasis model. Abstracts of 27th Ann Meeting of Am Soc Nephrol J Am Soc Nephr, p863.

53. Fouad Atmani, F. Jeff Opalko and S.R. Khan, 1994. Incorporation of osteopontin into calcium oxalate crystals induced in normal and stone formers urine. Abstracts of 27th Ann Meeting of Am Soc Nephrol J Am Soc Nephr, p859.

52. Fouad Atmani and S.R. Khan, 1994. Incorporation of macromolecules into calcium oxalate crystals induced in rat urine. Abstracts of 27th Ann Meeting of Am Soc Nephrol J Am Soc Nephr, p859.

51. Fouad Atmani and S.R. Khan, 1994. Characterization of uronic acid rich inhibitor isolated from rat urine. Abstracts of 27th Ann Meeting of Am Soc Nephrol J Am Soc Nephr, p858.

50. Zhao-Chen Hou and S.R. Khan, 1994. Localization of urinary stone lipids with malachite green. Proceedings of Florida Society for Microscopy, held May 5-6, 1994, Daytona Beach, Florida, p34.

49. Khan, S.R. and P.A. Glenton, 1994. Association between calcium oxalate and calcium phosphate crystals in nephrolithiasis. Abstracts of the 89th Annual Meeting of the American Urological Association, held May 14-29, San Fransisco, J. Urol. 151:425A.

48. Achilles, W., M. Kroning, A. Schaper, S. Khan, and H. Riedmiller, 1994. Specific nucleation by phospholipids of spherulitic calcium phosphate and calcium oxalate crystals in a gel matrix. Abstracts of the 5th European Urolithiasis Symposium, held April 21-23, 1994, Manchester, England, p41.

47. Gokhale, J.A., P.A. Glenton, and S.R. Khan, 1994. Analysis of Tamm Horsfall protein in a rat model of nephrolithiasis. Abstracts of the 5th European Urolithiasis Symposium, held April 21-23, 1994, Manchester, England, p91.

46. Kok, D.J. and S.R. Khan, Free or fixed particle mechanism. Abstracts of the 5th European Urolithiasis Symposium, held April 21-23, 1994, Manchester, England, p104.

45. Khan, S.R., P.O. Whalen and P.A. Glenton, 1993. Renal brush border membrane vesicles as heterogeneous nucleators of calcium oxalate crystals. Abstracts of the 88 Annual Meeting of the American Urological Association, held May 15-20, San Antonio, J. Urol. 149:440A.

44. Cohen, M.C., R.J. Lobinske, S.R. Khan and P.O. Whalen, 1993. Can Bacterial membranes contribute to calcium oxalate (CaOx) urolithiasis. Abstracts of the 88 Annual Meeting of the

65

American Urological Association, held May 15-20, San Antonio, J. Urol. 149:440A.

43. Khan, S.R., P.O, Whalen, A. Hevia and P. Glenton, 1993. Cellular membrane as heterogeneous nucleator of calcium oxalate crystals. Abstracts of the 4th European Symposium on Urolithiasis, held April 1-3, Tubingen, Germany, Urological Research 21: 156. 42. Gokhale, J.A., P.A. Glenton and S.R. Khan, 1993. Association of Tamm Horsfall Protein with renal calcium oxalate deposits in rats. Abstracts of the 4th European Symposium on Urolithiasis, held April 1-3, Tubingen, Germany, Urological Research 21: 155

41. Khan, S.R., J. Adair and R.L. Hackett, 1993. Pathological crystallization of calcium oxalate and calcium phosphate. Abstracts of the Spring Meeting of the Materials Research Society, page 422, held April 12-16, San Fransisco.

40. Khan, S.R., J. Finneli, P. Glenton, A. Morrone and J. Adair, 1993. Calcium phosphate deposition in rat kidneys. Abstracts of the Spring Meeting of the Materials Research Society, page 421, held April 12-16, San Fransisco.

39. Sindhu, S., K.V. Kurien, K.V., G.N. Subhanna, P. Koshy, S.R. Khan, and Y.M. Fazil Marickar, 1992. Purity of crystals grown in vitro on adding dopants. Abstracts of the VIIth International Symposium on Urolithiasis, held August 24-27, Cairns, Australia.

38. Cohen, M.C., R. Lobinske and S.R. Khan, 1992. Do bacterial membranes contribute to calcium oxalate (CaOx) crystal deposition. Abstracts of the VIIth International Symposium on Urolithiasis, held August 24-27, Cairns, Australia.

37. Adair, J.H., T. Nagira, S.R. Khan, C.M. Brown and W.C. Thomas, 1992. Heterogeneous deposition of calcium phosphates at the silicon (hydrous) xide-water interface. Abstracts of the VIIth International Symposium on Urolithiasis, held August 24-27, Cairns, Australia.

36. Hackett, R.L., P.N. Shevock and S.R. Khan, 1992. Inhibition of calcium oxalate monohydrate seed crystal growth is decreased in renal injury. Abstracts of the VIIth International Symposium on Urolithiasis, held August 24-27, Cairns, Australia.

35. Hackett, R.L., P.N. Shevock and S.R. Khan, 1992. Calcium oxalate crystals and ions are injurious to renal epithelial cells. Abstracts of the VIIth International Symposium on Urolithiasis, held August 24-27, Cairns, Australia.

34. Khan, S.R., C-J Su, P.N. Shevock, and R. L. Hackett, 1992. Beneficial effect of magnesium oxide administration on calcium oxalate urolithiasis. Abstracts of the VIIth International Symposium on Urolithiasis, held August 24-27, Cairns, Australia.

33. Khan, S.R., P.N. Shevock, J.D. Sallis and R. L. Hackett, 1992. Phosphocitrate as an inhibitor of calcium oxalate crystallization in vivo. Abstracts of the VIIth International Symposium on

66

Urolithiasis, held August 24-27, Cairns, Australia.

32. Khan, S.R. and R. L. Hackett, 1992. Renal epithelial injury: a risk factor in urolithiasis. Abstracts of the VIIth International Symposium on Urolithiasis, held August 24-27, Cairns, Australia.

31. Khan, S.R. and R. L. Hackett, 1992. Role of organic matrix in the formation and growth of calcium oxalate urinary stones. Abstracts of the VIIth International Symposium on Urolithiasis, held August 24-27, Cairns, Australia.

30. Mehta, Jawahar L., Nicolini, F.A., Nicholas, W.W., Khan, S.R. and T.G.P. Saldeen, 1992. Coronary artery narrowing distal to the thrombus after thrombolysis: Primary vasospasm or platelet activation. J. American College of Cardiology 19: 322A.

29. Nicolini, F.A., Nicholas, W.W., Saldeen, T.G.P., Khan, S.R. and J.L. Mehta, 1992. Adjunctive therapy with low molecular weight heparin with t-PA causes sustained reflow, but reperfused coronary arteries show residual thrombus. Proceedings of XIV Interamerican Congress of Cardiology, held May 23-27, Orlando. 28. Khan, S.R. and James C. Woodard, 1992. Structure of kidney stone removed from south american maned wolf. Proceedings of the 10th anniversary meeting of Florida Society for Electron Microscopy. page 14.

27. Khan, S.R., Su, C.J., Shevock, P.N. and R.L. Hackett, 1992. Magnesium oxide administration and experimental calcium oxalate urolithiasis. J. Urol. 147: page 331A.

26. Khan, S.R., and R.L. Hackett, 1991. Hyperoxaluria, enzymuria and nephrolithiasis. In: Abstracts of the VIIth International Symposium at Montecatini; Kidney, Proteins and Drugs, Held Montecatini Terme, Italy Oct. 14-16, page 22.

25. Khan, S.R., Su, C.J., Shevock, P.N. and R.L. Hackett, 1991. Effect of Magnesium oxide on calcium oxalate urolithiasis. J. Urol.

24. Normann, S., D. Saloman, P. Leelachaikul, S. Khan, E. Staples, J. Alexander, W. Mayfield, D. Knauf, L. Sadler, and S. Selman, 1991. Acute coronary artery rejection following heart transplantation. J. Heart and Lung Transpl., 10: page 192.

23. Khan, S.R. 1991. Backscattered imaging of plastic embedded decalcified human calcium oxalate dihydrate urinary stone. Proc. 26th Ann. S.E.E.M.S. Meeting, page 37.

22. Khan, S.R., P.N. Shevock, and R.L. Hackett, 1991. Renal injury and urinary excretion of enzymes after intraperitoneal administration of sodium oxalate. The FASEB Journal 5 (6): A1615.

21. Gokhale J.A. and S.R. Khan, 1990. Ultrastructure of microwave fixed rat kidneys. J. Electr. Microsc. Tech. 15: 418.

67

20. Khan, S.R., 1990. Ultrastructure of calcified IUDs. J. Elect. Micr. Tech. 15: 419.

19. Khan, S.R. and E.J. Wilkinson, 1989. Calcified intrauterine device as a bladder stone. J. Electr. Microsc. Tech. 13, 374.

18. Khan, S.R. and R.L. Hackett, 1989. Urinary enzymes in calcium oxalate urolithiasis. J.Urol. 141, 452A.

17. Khan, S.R. and R.L. Hackett, 1989. Hyperoxaluria and calcium oxalate relative supersaturation. J.Urol. 141, 452A.

16. Senior, D.F., J.M. Gaskin, C.D. Buergelt, S.R. Khan, D.A. Sundstrom, 1989. Effect of oral pentosan polysulfate and ovariohysterectomy on the clearance of experimentally induced bacterial cystitis in dogs. J. Urol. 141, 364A.

15. Khan, S.R. 1988. Struvite crystals in aseptic rat urine. Proceedings of the VIth annual meeting of the Florida Society for Electron Microscopy.

14. Khan, S.R. and R.L. Hackett, 1987. Lipids of human urinary stones. XX European Symposium on Calcified Tisssues, Sirmione, Italy, Calcified Tissue International 41, Supplement 2, p 63.

13. Khan, S.R. and R.L. Hackett, 1987. In vitro crystallization of calcium oxalate mediated by lipids of urinary stone matrix. XX European symposium on calcified tissues, Sirmione, Italy, Calcified Tissue International 41, Supplement 2, p 21.

12. Khan, S.R. and R.L. Hackett, 1987. Role of calcium oxalate crystal morphology in classification of Zygomyceters. 52nd Annual Meeting of the Mycological Society of America, Ottawa, Canada.

11. Khan, S.R. and R.L. Hackett, 1987. X-ray microanalysis for identification of foreign material in pathology specimens. Proceedings of the Vth Annual meeting of Florida Society for Electron Microscopy. p 26.

10. Khan, S.R. and R.L. Hackett, 1985. Concentric laminations in rat bladder foreign body stones: an SEM study. Proceedings of the IIIrd Annual Meeting of Florida Society for Electron Microscopy. p 7.

9. Newkirk, J.W. and S.R. Khan, 1984. The stability of calcium oxalate during electron irradiation in an AEM. Proc. of 2nd Annual Meeting of Florida Soc. Electr. Microsc.

8. Khan, S.R., B. Finlayson and R.L. Hackett, 1984. A microscopic study of the matrix of some calcium oxalate renal stones. Abstract, Vth Intl. Symp. Urol. Res., Garmisch, W. Germany, Urol. Res. 12, 92.

7. Khan, S.R., B. Finlayson and R.L. Hackett, 1984. Microstructure of calcium oxalate foreign body

68

stones. Abstract, Vth Intl. Symp. Urol. Res., Garmisch, W. Germany, Urol. Res. 12, 54.

6. Hackett, R.L. and S.R. Khan, 1984, Letter to the editor, Re: Increased urinary excretion of renal enzymes in idiopathic calcium oxalate nephrolithiasis. J. Urol. 131, 125.

5. Khan, S.R., R.L. Hackett and B. Finlayson, 1983. An experimental model for crystalluria. Abstract, Proc. IInd Nat. Conf. Urol. Soc. India, Trivandrum, India, 133.

4. Khan, S.R. 1983. Structure of bladder stones seen by electron microscopy. An interview published in Urology Times. 11, 16.

3. Khan, S.R., B. Finlayson and R.L. Hackett, 1982. Induction of rat bladder stones using plastic discs as foreign bodies. Presented at XIX Cong. Soc. Intl. Urol., San Francisco.

2. Finlayson, B., S.R. Khan and R.L. Hackett, 1982. Micropore structure of calcium oxalate stones. Presented at XIX Cong. Soc. Intl. Urol., San Francisco.

1. Khan, S.R. 1976. Electron microscopy as an aid in fungal taxonomy. Supplement to Aust. Pl. Pathol. Soc. Newslet. 5, 46.

69

curriculum vitae · web viewbot. 55, 730-739. 11. ... tiselius hg, 2001, methods for measuring...

Documents